Last Name:

First Name:

Eslami (Hassanabadi)

Saeid

E-mail address:

This email address is being protected from spambots. You need JavaScript enabled to view it.; This email address is being protected from spambots. You need JavaScript enabled to view it.

Personal Information

Marital status: Married

Birth date: 02-05-1974/12-02-1353

Place of Birth: Mashhad, Iran

Education

Ph.D. and Research Fellow

2004-2012                 Department of Medical Informatics, Faculty of Medicine,

                                  University of Amsterdam, Amsterdam, The Netherlands

Thesis title: “Pharmacotherapy and patient safety in intensive care: impact of guideline-base decision support”

Fellowship 1: Safety & quality of care in intensive care

Fellowship 2: Safety & quality of care of elderly

Pharm.D. (Doctor of Pharmacy)

1992-2000                      School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IRAN

Thesis title: “Design and Programming Multimedia database of drug information for the Iranian formulary”

Technical Experience

ü  Programming with Visual Basic 6 (professional level), particularly medical and pharmaceutical applications.

ü  Database programming with Visual Basic 6 and SQL

ü  Network Design with Windows NT & Advanced Server 2000 (good level)

ü  Hardware and computer assembly (level: good)

Teaching Experience

ü  Computer applications in pharmacy (for Ph.D. students in pharmaceutical sciences), 2000-2001

ü  Informatics and Internet (for Ph.D. students in pharmaceutical sciences), 2000-2001

ü  Computer applications in pharmacy and medicine (for Pharm.D. students), 1998-2000

ü  Computer application in dentistry and medicine (for D.D.S. students), 2000

ü  Information and Internet (for Pharm.D. students), 1997-2000

ü  Evaluation of decision support application (Medical informatics students), Amsterdam, 2007-2009

ü  Supervising and co-supervising two Medical Informatics master students, Amsterdam, 2008-2009

ü  Evaluation in Medical Informatics (Medical informatics Ph.D. students), Mashhad, 2011-

ü  Management of Medical Informatics Projects (Medical informatics Ph.D. students), Mashhad, 2011-

ü  Information and Information Sources in Medicine (Ph.D. students), Mashhad, 2012-

ü  Information and Information Sources in Medicine (M.Sc. students), Mashhad, 2012-

ü  Hospital Pharmacy (Pharm.D. students), Mashhad, 2012-

ü  Statistics (Toxicology M.Sc. student) , Mashhad, 2012-

ü  Research design and informatics (Toxicology Ph.D. students), Mashhad, 2012-

ü  Computer (Toxicology Ph.D. students), Mashhad, 2012-

ü  Applied projects (Medical informatics M.Sc. students), Mashhad, 2012-

ü  Decision Support systems (Medical informatics M.Sc. students), Mashhad, 2012-

ü  Statistics by non-mathematical approach, Workshop, Mashhad, 2012

ü  Systematic review, Workshop, Mashhad, 2012

ü  Supervising and co-supervising more than 10 Medical Informatics Ph.D. and Master students, 2012-

ü  Supervising and co-supervising more than 5 pharmacy and medical doctorate student, 2012

ü  …

Awards

ü  Third prize of Health and Hygiene group in 20th Razi Medial Science Festival, Iran, 2014

ü   Third prize of the Academic Medical Center’s safety projects, Amsterdam, The Netherlands, 2007

ü  Honor Researcher in Medical Informatics at Mashhad University of Medical Sciences, Mashhad, IRAN, 2002

ü  IT Consultant for President of Khorasan Province Food & Drug Administration, Mashhad, IRAN, 2001-2004

ü  Member of Information Technology Committee of Mashhad University of Medical Sciences, Mashhad, IRAN, 2000-2004

ü  Honor Student in Medical Informatics at Mashhad University of Medical Sciences, Mashhad, IRAN, 1998

Research Projects

ü  Designing a Clinical Registry for ICU Patients and Adopting, Calibrating and Validating APACHE and SAPS Mortality Prediction Models for Intensive Care Units in Iran, 2013-

ü  Designing and Evaluating of an E-learning System for Pharm.D. Students on Reading the Medications in the  Prescriptions, 2013-

ü  Effect of drug therapy on the continuity of care of patients with depressive and/or stress disorders, 2013- 

ü  Designing and Evaluation of Feedbacks Based on Decision Support System on Frequency of Drug-Drug Interactions among Prescriptions in Mashhad, 2013-

ü  Evaluation of the quality of pharmaceutical services in community pharmacies, sources of information and level of knowledge of pharmacists in Mashhad and suggesting reform plans, 2013-

ü  Evaluating the sufficiency of  the ultrasonography reports of patients suspected to NAFLD and developing a valid structured Reporting model, 2013-

ü  Effective factors in information exchange between patient and physician and suggesting IT based interventions to improve, 2013-

ü  Empowering pregnant woman by IT Interventions, 2012-

ü  Clinical decision support system for diagnosis of patients with Non-Alcoholic Fatty Liver Disease (NAFLD), 2012-

ü  Designing and evaluation of an IT-Based feedback system to change the behavior of general practitioners of Kerman province to reduce inappropriate parenteral corticosteroids prescription, 2012-

ü  Designing a registry for occupational hazards in hospitals and investigating the effect of reforms in the way of informing and education on clinical staff safety, 2012-

ü  Improving Care of Vulnerable Elders (ICOVE), 2009-

ü  Effect of four levels of computerized decision support (from non-critiquing and patient non-specific till critiquing and patient-specific) on adherence to aminoglycoside guideline; and frequency of errors and adverse drug events, 2004-

ü  Effect of two levels of decision support on antibiotics prescription - effectiveness and cost-benefit, 2004-

ü  Effect of a critiquing and non-critiquing decision support system for different target groups (physicians, nurses and both) on adherence to lung protective mechanical ventilation strategy, 2005-2011

ü  Effect of two levels of decision support (patient non-specific, patient specific) on adherence to guideline and glucose regulation, 2005-2011

ü  Systematic literature reviews on CPOE in outpatients, CPOE in inpatients, quality indicators for glucose regulation, decision support for glucose regulation, 2004 -2012

ü  Design and development of simulator software for reading prescriptions  in pharmacies, 1998-2000

ü  Design and Programming a Windows-based software for Iranian Outpatient- and Inpatient-Pharmacies, 1994-2004

ü  Design and Programming multimedia database of drug information for the  Iranian formulary, 1998

ü  Design and Programming a Windows-based software for libraries of Mashhad University of Medical Sciences, Mashhad, IRAN, 1996

Courses and Workshops

ü  Decision Support Systems, Mashhad, Iran, Sep 2012

ü  Electronic Health Records, Mashhad, Iran, Sep 2012

ü  Statistics in Medicine, Mashhad, Iran, Sep 2012

ü  Great Survey Design, Amsterdam, The Netherlands, July 2012 – August 2012

ü  ATC/DDD methodology (organized by WHO), Oslo, Norway, June 2012

ü  Epidemiolgy (organized by European Renal Association - European Dialysis and Transplant Association), Amsterdam, The Netherlands, Jan-Feb 2012

ü  Better use of PubMed, Amsterdam, The Netherlands, Jan 2012

ü  Statistical computing in R, Amsterdam, The Netherlands, Nov 2011

ü  Longitudinal studies, Amsterdam, The Netherlands, 2010

ü  Prognostic models, Amsterdam, The Netherlands, 2010

ü  Introduction to Bioinformatics, Amsterdam, The Netherlands, Feb 2009

ü  Erasmus summer programme, Rotterdam, The Netherlands, Aug 13-31, 2007

-          Clinical Trials

-          Regression Analysis

-          Pharmaco-epidemiology

-          The why and how of readable articles

ü  Advanced Bio-statistics Amsterdam, The Netherlands, Sept 4-Oct 5, 2006

ü  Practical Bio-statistics, Amsterdam, The Netherlands, Oct-Nov, 2005

ü  Oral Presentation in English, Amsterdam, The Netherlands, 2005

ü  Scientific Writing in English for Publication-Writing to be read, Amsterdam, The Netherlands, Oct-Dec, 2005

ü  International Masterclass for Medical Informatics, Heidelberg/Heilbornn/Bad Wimpfen, Germany, July 16-20, 2005

ü  Health Informatics: the role of informatics in health care- the Amsterdam International Medical Summer School, Amsterdam, The Netherlands, July 11-23, 2004

ü  The Netherlands Medical Informatics Ph.D. days:

-          Utrecht, Jan, 2005

-          Mastricht, Jan, 2006

-          Nijmegen, Feb, 2007

-          Zeeland, March, 2008

-          Amsterdam, Jan, 2009

-          Zeeland, March, 2010

-          Amsterdam, March 2011

-          Breukelen, March 2014

Superviser or Co-superviser

SarafiNejad A, Designing and evaluation of an IT-Based feedback system to change the behavior of general practitioners of Kerman province to reduce inappropriate parenteral corticosteroids prescription-Using SMS, Medical Informatics PhD Thesis, Iran
Nabovati E, Designing and Evaluation of Feedbacks Based on Decision Support System on Frequency of Drug-Drug Interactions among Prescriptions in Mashhad, Medical Informatics PhD Thesis, Iran
Sarbaz M, Designing a web-based registry for occupational incidents in hospitals and investigating the effect of reforms in the way of informing and education on clinical staff safety, Medical Informatics PhD Thesis, Iran
Aslani A, Effects of Information Technology (information system and decision aid) on Empowering Pregnant Woman- Mashhad, 2012, Medical Informatics PhD Thesis, Iran

Pournik O, Computerized decision support system for non alcoholic fatty liver disease diagnosis, Medical Informatics PhD Thesis, Iran (First Iranian graduated student in PhD of Medical Informatics)

Aamer, PharmD Thesis, Iran

Askari M., Investiagting drug-drug interactions and preventing them by a decision support system, Medical Informatics Master Thesis, The Netherlands

Opondo D., Assessing the quality of care for the elderly in gereral practice. Medical Informatics Master Thesis, The Netherlands (selected as the best Medical Informatic Master thesis in 2011 in the Netherlands)

Publications

v  ISI publications

1)      Eslami S, Sahebkar A. Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies. Current hypertension reports. 2014;16(6):432.

2)      Van de Glind EM, Willems HC, Eslami S, Abu-Hanna A, Lems WF, Hooft L, et al. Estimating the Time to Benefit for Preventive Drugs with the Statistical Process Control Method: An Example with Alendronate. Drugs & aging. 2016.

3)      Wlodzimirow KA, Eslami S, Chamuleau RA, Nieuwoudt M, Abu-Hanna A. Prediction of poor outcome in patients with acute liver failure-systematic review of prediction models. PloS one. 2012;7(12):e50952.

4)      Askari M, Eslami S, Medlock S, de Rooij SE, Abu-Hanna A. Fall-related Information seeking behavior of seniors on the web. Studies in health technology and informatics. 2014;205:647-51.

5)      Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA. A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality. Liver international : official journal of the International Association for the Study of the Liver. 2013;33(1):40-52.

6)      Sahebkar AH, Eslami S. Glutathione-S-Transferase M1 and T1 Null Genotypes Are Associated with Hypertension Risk: A Meta-Analysis of 12 Studies. Current Hypertension Reports 2014, Accepted.

7)      Eslami S et al. From assessment to improvement of elderly care in general practice using decision support to increase adherence to ACOVE quality indicators: study protocol for randomized control trial. Trials 2014, 19;15(1):81.

8)      Nabovati E, Vakili-Arki, H, Eslami S, Khajouei R. Usability Evaluation of Laboratory and Radiology Information Systems Integrated into a Hospital Information System. Journal of Medical Systems 2014, 38:35.

9)      Pournik O, …, Eslami S. A Diagnostic Model for Cirrhosis in Non-Alcoholic Fatty Liver Disease Patients; An Artificial Neural Network Approach. Med J Islamic Republic of Iran 2014, Accepted.

10)  Pournik O, ..., Eslami S. Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies. Hepat Mon. 2014 January; 14(1): e15167.

11)  Askari M, …, Eslami S et al. Verschil in geneesmiddelengebruik tussen ouderen met een eenmalige val versus frequente vallers (in Dutch). Nederlands Tijdschrift voor Geneeskunde 2014, Accepted.

12)  Arts DL, …, Eslami S, van Weert HCPM. Improving stroke prevention in patients with atrial fibrillation. Trials 2013, 14:193.

13)  Pournik O, ..., Eslami S. Lower intrafamilial transmission rate of hepatitis B in patients with hepatitis D coinfection : A Data-mining approach. Hepatitis Monthly 2013. Accepted

14)  Medlock A, Eslami S et al. Co-prescription of gastroprotective agents and their efficacy in elderly patients taking nonsteroidal anti-inflammatory drugs: a systematic review of observational studies. Gasteroentrology and hepatitis 2013. Accepted.

15)  Askari M, Eslami S et al. Different risk-increasing drugs in recurrent versus single fallers: are recurrent fallers a distinct population? Drugs and Aging 2013, Accepted

16)  Askari M, …, Eslami S et al. A combined disease management and process modeling approach for assessing and improving care processes: A fall management case-study. Int J Med Inform, Accepted

17)  Askari M, Eslami S et al. Frequency and nature of Drug-drug Interaction in the Intensive Care Unit. Pharmacoepidemiology & Drug Safety 2013; Accepted.

18)  Pournik O, Alavian SM, Eslami S. Can We Accurately Assess Liver Fibrosis with Fibroscan® Using Fewer Valid Measurements? Yonsei Med J; Accepted.

19)  Wlodzimirow KA, Eslami S et al. Prediction of poor outcome in patients with acute liver failure-systematic review of prediction models. PLoS ONE  2012; 7(12).

20)  Opondo D, Eslami S et al. Inappropriateness of medication prescriptions to elderly patients in primary care: A Systematic Review. PLoS ONE 2012; 7(8).

21)  Wlodzimirow KA, Eslami S et al. Systematic review: acute liver failure - one disease, more than 40 definitions.  Alimentary Pharmacology & Therapeutics 2012; 35(11):1245-56

22)  Wlodzimirow KA, Eslami S et al. A Systematic Review on prognostic indicators of human Acute on Chronic Liver Failure and their predictive value for mortality. Liver International 2013; 33(1):40-52

23)  Minne L, Eslami S et al. Five years of therapeutic drug monitoring in the intensive care did not change vancomycin prescription behaviour: perceived needs for decision support. Minerva Anestesiologica 2012 Jun;78(6):684-92

24)  Wlodzimirow KA, Eslami S et al. Acute liver failure – What is it? Hepatology 2012; 55(4):1306-7.

25)  Minne L, Eslami S et al. Statistical process control for monitoring standardized mortality ratios of a classification tree model. Methods Inf. Med. 2012;51(4):353-8

26)  Askari M, Wierenga P, Eslami S et al. Assessing Quality of Care of Elderly patients using the ACOVE quality indicator set: A Systematic Review PLoS ONE 2011; 6(12):e2863.

27)  Meynaar IA, Eslami S et al. Blood glucose amplitude variability as predictor for mortality in surgical and medical ICU patients - A multicenter cohort study. J Crit Care 2012; 27(2):119-24

28)  Eslami S et al. Effects of two different levels of computerized decision support on blood glucose regulation in critically ill patients. Int J Med Inform 2011, 81(1):53-60

29)  Minne L, Eslami S et al. Statistical Process Control for validating a classification tree model for predicting mortality - a novel approach towards temporal validation. J Biomedical Informatics 2011; 45(1):37-44

30)  Eslami S et al. Evaluation of consulting and critiquing decision support         systems: Effect on adherence to a lower tidal volume mechanical ventilation strategy. J Crit Care 2012 Aug;27(4):425.e1-8

31)  Askari M, Wierenga PC, Eslami S, et al. Studies Pertaining to the ACOVE Quality Criteria: A Systematic review. Int J for Qual in Health Care 2011; 24(1):80-7

32)  Minne L, Eslami S et al. Effect of changes over time in the performance of a customized SAPS-II model on quality of care assessment. Intensive Care Medicine 2012; 38(1):40-6

33)  Medlock S, Eslami S et al. Improved communication in post-ICU care by improving writing of ICU discharge letters: a longitudinal before-after study. BMJ Quality & Safety 2011; 20(11):967-73

34)  Medlock S,  Opondo D, Eslami S, Askari M, Wierenga P, de Rooij SE, Abu-Hanna A. LERM (Logical Elements Rule Method): A method for assessing and formalizing clinical rules for decision support. Int. J of Med Inform.  2011;  80(4):286-95.

35)  Eslami S, Taherzadeh Z, Schultz MJ, Abu-Hanna A. Glucose variability measures and their effect on mortality – A systematic review. Intensive Care Med. 2011; 37(4):583-93.

36)  Eslami S, Abu-Hanna A. Acceptance of drug-drug interaction alerts and alert system design. Br J Clin Pharmacol. 2010 Oct;70(4):619-20.

37)  Eslami S, Abu-Hanna A, de Keizer NF, Bosman RJ, Spronk PE, de Jonge E, Schultz MJ. Implementing glucose control in intensive care: a multicenter trial using statistical process control. Intensive Care Med. 2010 Sep;36(9):1556-65.

38)  Eslami S, Abu-Hanna A, de Jonge E, de Keizer NF. Tight glycemic control and clinical decision support – A systematic review. Intensive Care Medicine.2009 Sep;35(9):1505-17.

39)  Eslami S, de Keizer NF, de Jonge E, Schultz M, Abu-Hanna A. A systematic review on quality indicators for tight glycaemic control in critically ill patients; the need for unambiguous indicator reference subset. Critical Care 2008;, 12:R139.

40)  Eslami S, Abu-Hanna A, de Keizer NF, de Jonge E, Schultz M. Effect of a clinical decision support system on adherence to a lower tidal volume mechanical ventilation strategy. Journal of Critical Care 2009; 24(4):523-9.

41)  Eslami S, de Keizer NF, Abu-Hanna A. The impact of computerized physician medication order entry in hospitalized patients - A systematic review. Int. J of Med Inform. 2008; 77(6):365-76.

42)  Eslami S, Abu-Hanna A, de Keizer NF. Evaluation of outpatient computerized physician medication order entry systems: a systematic review. J Am Med Inform Assoc. 2007 Jul-Aug;14(4):400-6.

43)  Eslami S, Abu-Hanna A, de Keizer NF, de Jonge E. Errors associated with applying decision support by suggesting default doses for aminoglycosides. Drug Saf. 2006;29(9):803-9.

v  Medline indexed publications

44)  Aslani A, …, Eslami S. Pregnant women's information seeking. Stud Health Technol Inform. 2014; Accepted.

45)  Hejazi Y, …, Eslami S. e-Learning System for PharmD Students-Feasibility and Preliminary Result of a Randomized Controlled Trial. Stud Health Technol Inform. 2014; Accepted.

46)  Pournik O, …, Eslami S. Evaluation of a Computer-based Clinical Decision Support System on physician performance and patient outcome of Non-Alcoholic Fatty Liver Disease Patients. Stud Health Technol Inform. 2014; Accepted.

47)  Aalaei S, …, Eslami S. Blood BagTemperature Monitoring System. Stud Health Technol Inform. 2014; Accepted.

48)  Aslani A, …, Eslami S. Web-site Evaluation Tools: Reproductive Health Information. Stud Health Technol Inform. 2014; Accepted.

49)  Askari M, Eslami S et al. Fall-related Information seeking behavior of seniors on the web. Stud Health Technol Inform. 2014; Accepted.

50)  Aslani A, …, Eslami S. The impact of a computerized decision aids on   mode of delivery-Study protocol. Stud Health Technol Inform. 2014; Accepted.

51)  Medlock S, Eslami S et al. The Consequences of Seniors Seeking Health Information Using the Internet and Other Sources. Stud Health Technol Inform. 2013; Accepted

52)  Medlock S, Eslami S et al. Attitudes and Experience of Dutch General Practitioners Regarding Computerized Clinical Decision Support. Accepted. Stud Health Technol Inform. 2013;186:56-60.

53)  Askari M, Eslami S, et al. Relevance of drug-drug interaction in the ICU - Perceptions of intensivists and pharmacists. Stud Health Technol Inform.  2012;180:716-20

54)  Medlock S, Eslami S, et al. Application of the Logical Elements Rule Method for formalization of clinical rules: case study of ACOVE-NLI. Stud Health Technol Inform. 2012;180:421-6

55)  Abu-Hanna A, Eslami S, Schultz MJ, de Jonge E, de Keizer NF. Analyzing effects of providing performance feedback at ward rounds on guideline adherence - the importance of feedback usage analysis and statistical control charts. Stud Health Technol Inform. 2010;160:826-30.

56)  Tavakkoli M, ..., Eslami S. Omega-3 and Omega-6 Content of Medicinal Foods for Depressed Patients: Implications from the Iranian Traditional Medicine. Avicenna J of Phytomedicine 2014, Accepted.

v  Embase indexed publications

57)  Wlodzimirow KA, Eslami S et al. A systematic review on prognostic indicators of acute liver failure and their predictive value for poor outcome. British Journal of Medicine & Medical Research. 2014; 4(15):2796-2852.

58)  Medlock S, Eslami S et al. Health information seeking behavior of elderly Internet users in the Netherlands. European Geriatric Medicine 2012; 3 (pp S90-S91) (8th Congress of the European Union Geriatric Medicine Society Brussels Belgium).

59)  Eslami S, Abu-Hanna A, de Keizer NF, de Jonge E, Schultz M. Decision support to increase adherence to a mechanical ventilation guideline: A study protocol and first results. Intensive Care of Medicine 2008; 34 (pp S78) (21st Annual Congress of the European Society of Intensive Care Medicine, ESICM Lisbon Portegal).

60)  Eslami S., De Keizer N.F., Taherzadeh Z., Schultz M.J., Abu-Hanna A. Tight glycaemic control and computerized decision support systems-future and challenges. Diabetes Technology and Therapeutics 2011; 13 (2) (pp 182). (4th International Conference on Advanced Technologies and Treatments for Diabetes, ATTD 2011 London United Kingdom).

61)  Eslami S., Abu-Hanna A., De Keizer N.F., De Jonge E., Dongelmans D., Schultz M.J. Effects of two levels of computerized decision support on glucose regulation in intensive care-using statistical process control. Intensive Care Medicine 2009; 35  (pp S236). (22nd Annual Congress of the European Society of Intensive Care Medicine, ESICM Vienna Austria).

62)  Eslami S., De Keizer N.F., De Jonge E., Abu-Hanna A. Improving medication safety in the intensive care unit by implementing computerized decision support system-using statistical process control. Intensive Care Medicine 2009; 35  (pp S235). (22nd Annual Congress of the European Society of Intensive Care Medicine, ESICM Vienna Austria).  

63)  Eslami S., Abu-Hanna A., De Keizer N.F., Bosman R.J., Spronk P.E., De Jonge E., Schultz M.J. Implementing Glucose regulation guidelines in intensive care - A multicenter trial using statistical process control. Basic and Clinical Pharmacology and Toxicology 2009; 105  (pp 33-34). (9th Congress of the European Association for Clinical Pharmacology and Therapeutics Edinburgh United Kingdom). 

v  Other publications

64)  Eslami S et al. Lessons learned from implimentating and evaluating computerized decision support systems. Lecture Notes in Artificial Intelligence 2011; 6747:101-108

65)  Medlock S, Eslamia S, Askaria M, de Rooijb S, Abu-Hanna A. Improving Care Of Vulnerable Elders (ICOVE): the road from quality indicators to quality improvement.  VMBI Yearbook 2010.

66)  Eslami S, de Keizer NF, Schultz MJ, de Jonge E, Abu-Hanna A. Pharmacotherapy and patient safety in intensive care-Impact of guideline-based decision support. VMBI Yearbook 2009; 17-21.

67)  Eslami S. (2009) Pharmacotherapy and patient safety in intensive care-Impact of guideline-based decision support. Amsterdam: Ponsen & Looije.

v  Submitted and ready to submit manuscripts

68)  Amenability of ACOVE quality indicators for automatic evaluation in general practice care in the Netherlands

69)  The association between blood glucose variability and hospital mortality is dependent on the blood glucose control guideline in use

70)  From assessing to improvement – Protocol of a randomized control trial using ACOVE quality indicators to improve quality of elderly care in outpatient setting

71)  A multi-center study on end-of-life decision-making in the Intensive Care: Differences between physicians’ perceptions and clinical practice

72)  Improving stroke prevention in atrial fibrillation – Protocol of A RCT study

73)  Impact of half-life definitions between drug administration times on frequency of DDIs - A novel step toward detecting relevant DDIs

74)  Influence of electronic medical record systems on physicians response to drug safety warnings

75)  Three or more valid measurements for assessing liver fibrosis using FibroScan® in Patients with Chronic Viral Hepatitis

76)  Feasibility of automatic evaluation of quality of care based on quality indicators in general practice

77)  For which tasks do doctors want decision support, and why? A survey of Dutch general practitioners.

78)  …

Presentations in seminars

ü  Prognostic models for benchmarking-adaptation and implementation. 3^rd Conference on Health Tourism in Islamic Countries, Mashhad, December 2012

ü  Web-site Evaluation Tools: Reproductive Health Information. 13^th International Congress of Gynecology & Obstetrics, Tehran, December 2012 (co-author)

ü  Eight Years’ Experience in Designing, Implementation and Evaluation of Computerized Decision Support Systems in the Netherlands – Futures and Challenges; and Lessons Learned for Iran, 1^st International Conference on Electronic Health, Tehran, November 2012

ü  Lessons learned from designing, implementing and evaluating decision support system, 1^st Seminar on Intelligent Laboratory, Tehran, November 2012

ü  Met Statistical Process Control (SPC) kan de time-to-benefit van preventieve medicatie gemakkelijk en inzichtelijk bepaald worden.  Een voorbeeld met alendronaat. (in Dutch, co-author)

ü  Health information seeking behavior of elderly internet users in the Netherlands, EUGMS, Brussels, Sept 2012 (co-author)

ü  Fall-related information seeking behavior among elderly internet-users 21st Nordic Congress of Gerontology - Dilemmas in Ageing Societies, Copenhagen, June 2012 (co-author)

ü  Lessons learned from implimentating and evaluating computerized decision support systems, Artificial Intelligence in Medicine (AIME), Bled, 2011

ü  ??, International Forum on Quality and Safety in Health Care, Amsterdam, 2010 (co-author)

ü  Tight Glycaemic Control and Computerized Decision Support Systems – future and challenges (invited speaker), Advanced Technologies & Treatments for Diabetes (ATTD), London, 2011

ü   Implementing Glucose Regulation guidelines in Intensive Care – A Multicenter trial Using Statistical Process Control, The 9th Congress of the European Association for Clinical Pharmacology and Therapeutics, Edinburgh, 2009

ü  Critiquing vs. non-critiquing decision support: Effect on adherence to a lung-protective mechanical ventilation protocol, 10th Congress of WFSICCM, Florence, 2009

ü  Effects of two levels of computerized decision support on glucose regulation in intensive care –Using statistical process control, European association of Intensive Care Medicine (ESICM), Vienna, 2009

ü  Improving medication safety in the intensive care unit by implementing computerized decision support system- Using statistical process control, European association of Intensive Care Medicine (ESICM), Vienna, 2009

ü  Decision support to increase adherence to a mechanical ventilation guideline: a study protocol and first results, European association of Intensive Care Medicine (ESICM), Lisbon, 2008

ü  Can Default Dose Introduce New Source of Errors, International Forum on Quality and Safety in Health Care, Barcelona, 2007

ü  Multimedia Database of Iranian Drugs Interactions, 16^th Iranian Congress of Physiology & Pharmacology, Tehran, 2003

ü  Simulator software for prescription reading in pharmacies, 8^th Iranian Pharmaceutical Sciences Seminar, Shiraz, 2002

ü  Reform of drug distribution in hospitals with computer, 1^th Food and Drug Usage Seminar, Sari, 2000

ü  Multimedia searcher for pharmaceutical and toxic agents in Iran, 6^th Iranian Toxicology and Drug Poisoning Congress , Ahvaz, 1999

ü  Lecturer in various continuing education courses for Iranian pharmacists, topics include computer applications in pharmacy, 1999-2004

^ü    Multimedia database of drug information in Iranian formulary, 5^th Iranian Pharm.D. Student Seminar, Tehran, 1999

ü  Education Technology in Iran, 5^th Iranian Pharm.D. Student Seminar, Tehran, 1999

ü  Multimedia database of Iranian medicinal plants, 1^th Medicinal Plant and Industry, Tehran, 1997

^ü    Antimicrobial activity of Iranian plant (Khorasan province), 3^th Iranian Pharm.D. Student Seminar, Tehran, 1996

^ü    Library management software, 2^th Iranian Phrm.D. Student Seminar, Mashhad, 1995

ü  Anti HIV drug advice,1^th Iranian Pharm.D. Student Seminar, Tabriz, 1994

^ü    Design of Iranian plant systematic poster, 1^th Iranian Pharm.D. Student Seminar, Tabriz, 1994

Membership

ü  Presidency of Islamic Republic of Iran National Elites Foundation, 2016-

ü  Dutch Association of Medical Informatics, 2008-

Mohsen Tafaghodi (Pharm.D., Ph.D.)

Professor in Pharmaceutics and Nanotechnology

Address:

School of Pharmacy,

Nanotechnology Research Center,

Mashhad University of Medical Sciences,

Mashhad-Iran

Tel: ++98-51-38823255-66 (Office)

Fax: ++98-51-38823251

tafaghodim[at]mums.ac.ir

Updated at:  June 2016                         

                                                       und Educational Background 

Pharm.D.: School of Pharmacy, Mashhad University of Medical Sciences (1991-1997).

Ph.D. (Pharmaceutics): School of Pharmacy, Mashhad University of Medical Sciences (1997-2003). Ph.D. thesis title: Nasal immunization using biodegradable microspheres and liposomes: Tetanus toxoid as a model

Research fellowships:

1-      School of Pharmacy, University of Alberta, Canada (cancer vaccination using nano- and microparticulate drug delivery systems). 2001.

2-      Leiden/Amsterdam center for Drug Research, University of Leiden, Netherland (preparation and characterization and in vivo study of TMC:HBsAg and chitosan:HBsAg nanoparticles as a nasal delivery /adjuvant system). 2011.

Research Interests

Mucosal and systemic vaccine and drug delivery by nanoparticulate and microparticulate delivery systems (nanospheres, microspheres and liposomes)

Publications

Books

1. Tafaghodi, M., Amiri, R., Hosseinzadeh, H., 1998. Adverse Effects of Herbal Drugs. Volume 1, MUMS Press, Mashhad. (Translation), 4^th print 2007.

2. Tafaghodi, M., Hosseinzadeh, H., 2002. Adverse Effects of Herbal Drugs. Volume 2, MUMS Press, Mashhad. (Translation), 3^rd print, 2007.

3. Hosseinzadeh, H., Tafaghodi, M., 2006. Adverse Effects of Herbal Drugs. Volume 3, MUMS Press, Mashhad. (Translation).

4. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., 2006. Pharmacetics, the science of dosage form design. Volume 1, MUMS Press, Mashhad. (Translation, 2^nd print, 2009).

5. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., Fazly, B.S., 2007. Pharmacetics, the science of dosage form design. Volume 2. (Translation), 2^nd print, 2010.

6. Imenshahidi, M., Moallem, S.A., Tafaghodi, M., Rezaei, Ramin, Firouzi, Zohreh, 2011. Nonprescription Drug Therapy. MUMS press, Mashhad. (Translation)

7. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., Fazly, B.S., 2013. Aulton’s Pharmacetics, the design and manufacture of medicines. Volume 1, MUMS Press, Mashhad. (Translation, 2015).

8. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., Fazly, B.S., 2013. Aulton’s Pharmacetics, the design and manufacture of medicines. Volume 2, MUMS Press, Mashhad. (Translation, 2015).

Papers

1- Diwan, M., Tafaghodi, M., Samuel, J., 2002. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. Journal of Controlled Release, 85, 247-262

2- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2002. Drug delivery from nasal route. Razi,, 155, 32-42.

3- Tafaghodi, M., Hasanzadeh, M., Rahimizadeh, M., 2003. Isolation and identification of Hyoscyamus insanus alkaloids. Iranian journal of Medicinal Plants, 2(7), 29-36.

4- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2004. Utilization of particulate and immuno-modulating adjuvants for enhancement of immune responses against tumors antigenic markers. Iranian Journal of Basic Medical Sciences, 6(4), 336-345.

5- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., Zakavi, S.R., Momen-nejad, M., 2004. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. International Journal of Pharmaceutics, 280, 125-135.

6- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2004. Mucosal immunization. Razi, 175, 17-24.

7- Tafaghodi, M., Jaafari, M.R.., Sajadi Tabasi, S.A., 2004. Adjuvants. Razi, 174, 34-45.

8- Sajadi Tabasi, S.A., Tafaghodi, M., Jaafari, M.R., 2004. Dextran microspheres encapsulated with tetanus toxoid as a delivery system for nasal immunization: in vitro and in vivo characterization.  Iranian Journal of Basic Medical Sciences, 7(2), 88-98.

9- Jaafari, M.R., Tafaghodi, M., Sajadi Tabasi, S.A., 2005. Evaluation of the clearance characteristics of liposomes in the human nose by gamma-scintigraphy. Iranian Journal of Pharmaceutical Research, 4(1), 3-11.

10- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2006. Formulation and characterization and release studies of alginate microsphere encapsulated with tetanus toxoid. Journal of Biomaterials Science. Polymer Edition., 17(8), 909-924.

11- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2006. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN. International Journal of Pharmaceutics, 319, 37-43.

12- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2006. Nasal immunization studies by liposomes encapsulated with tetanus toxoid and CpG-ODN. European Journal of Pharmaceutics and Biopharmaceutics, 64, 138-145.

13- Tafaghodi, M., Jaafari, M.R., Nikouzadeh, A. 2007. Evaluation of systemic and mucosal immune responses following the nasal immunization by various sizes of liposomes encapsulated with tetanus toxoid. Iranian Journal of Basic Medical Sciences, 9, 4(32), 307-315.

14- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2007. Nasal immunization study by PLGA nanospheres encapsulated with tetanus toxoid and CpG-ODN. Iranian Journal of Pharmaceutical Research, 6(3), 151-158.

15- Ghiasi, Z., Sajadi Tabasi, S.A., Tafaghodi, M., 2007. Preparation and In Vitro  Characterization of Alginate Microspheres Encapsulated with Autoclaved Leishmania major (ALM) and CpG –ODN. Iranian Journal of Basic Medical Sciences, 10(2), 90-98.

16- Tafaghodi, M., Sajadi Tabasi, S.A., Payan, M., 2007. Alginate microspheres as delivery system and adjuvant for autoclaved Leishmania major (ALM) and Quillaja saponin (QS) - Preparation and characterization. Iranian Journal of Pharmaceutical Sciences, 3(2), 61-68.

17- Nazemian, F., Mohammad-Poor, A-H, Naghibi, M, Hasanzadeh-Khayat, M., Tafaghodi, M., Charkazi, S, Abrisham, S., 2007. The effect of pentoxiphylline on hemoglobin levels in patients with erythropoietin resistant anemia in hemodialysis patients. Nephrology Dialysis Transplantation, 22(Supplement 6), 355-355.

18- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2008. Nasal immunization studies by cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid. Current Drug Delivery, 5, 108-113.

19- Tafaghodi, M., Sajadi Tabasi, S.A., Kharazizadeh, M., 2008. Preparation and characterization of PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and Quillaja saponin. Saudi Pharmaceutical Journal, 16(1), 43-49.

20- Sajadi Tabasi, S.A., Tafaghodi, M., Jaafari, M.R., 2008. Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran  microspheres. International Journal of Pharmaceutics, 360, 12-17.

21- Tafaghodi, M., Hadizadeh, F., Farahmand, F., 2008. Comparison of spectrophotometry and spectroflourimetry methods in determination of encapsulation efficiencies of TT in microspheres and liposomes, Pharmaceutical Sciences, summer, 53-59.

22- Tafaghodi, M., Sajadi Tabasi, S.A., Amiri, N., 2008. PLGA nanospheres loaded with Autoclaved Leishmania Major (ALM) and CpG-ODN: Preparation and in vitro characterization. Iranian Journal of basic medical Sciences, 11(2), 112-119.

23- Deldar, K., Nazemi, E., Balali Mood, M., Emami, S.A., Mohammadpour, A.H., Tafaghodi, M., Afshari, R., 2008. Effect of Coriandrum sativum L. extract on lead excretion in 3-7 year old children, Journal of Birjand University of Medical Sciences, 15, 11-19.   

24- Amin, M.R., Jaafari, M.R., Tafaghodi, M., 2009. Nasal immunization studies in rabbits by anionic and chitosan coated liposomes encapsulated with tetanus toxoid as a model antigen. Colloids and Surfaces B. Biointerfaces, 74, 225-229.

25- Khadivzadeh, T., Samadi, S., Emami, A., Tafaghodi, M., Sanjar Moosavi, N., Behnam, H.R., 2010. The Effect of Hypericum Perforatum on the Wound Healing and Scar of Cesarean. Journal of Alternative and Complementary Medicine, 16(1), 113-117.

26- Tafaghodi, M., Rastegar, S., 2010. Preparation and in vivo study of dry powder microspheres for nasal immunization. Journal of Drug Targeting, 18(3), 235-242.

27- Emami, S.A., Fakhrjafary, M., Tafaghodi, M., Hassanzadeh, M.K., 2010. Chemical Composition and Antioxidant Activities of the Essential Oils of Different Parts of Cupressus arizonica Greene. Journal of Essential Oil Research, 22, 193-199.

28- Tafaghodi, M., Jaafari, M.R., Eskandari, M., Khamesipour, A., 2010. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental Autoclaved Leishmania major (ALM) and Quillaja saponins. Tropical Biomedicine, 27, 639-650.

29- Alipour, S., Montaseri, H., Tafaghodi, M., 2010. Preparation and characterization of paclitaxel loaded alginate microparticles for pulmonary delivery. Colloids and Surfaces B. Biointerfaces, 81, 521-529.

30- Mohaghegh, M., Tafaghodi, M., 2011. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit. Pharmaceutical Development and Technology, 16, 36-43.

31- Tafaghodi, M., Khamesipour, A., Jaafari, M.R., 2011. Immunization against leishmaniasis by PLGA nanospheres encapsulated with Autoclaved Leishmania major (ALM) and CpG-ODN. Parasitology Research, 108, 1265-1273.

32- Tafaghodi, M., Eskandari, M., Khamesipour, A., Jaafari, M.R., 2011. Alginate microspheres encapsulated with Autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis. Experimental Parasitology, 129, 107-114.

 33- Maleki, M., Karimi, G., Tafaghodi, M., Raftari, S., Nahidi, Y., 2012. Comparison of Intralesional 2% zinc sulfate and Glucantime injection in treatment of acute cutaneous Leishmaniasis. Indian Journal of Dermatology, 57, 118-122.

34- Tafaghodi, M., Eskandari, M., 2012. The mucosal adjuvant potential of cross-linked dextran microspheres (CDM) as dry powder. Iranian Journal of Basic Medical Sciences, 15, 873-879.

35- Moghadam Aryaee, F., Tafaghodi, M., 2012. Mucosal adjuvant potential of Quillaja saponins and cross-linked dextran microspheres, co-administered with liposomes encapsulated with tetanus toxoid. Iranian Journal of Pharmaceutical Research, 11(3), 723-732.

36- Khodaverdi, E., Tafaghodi, M., Ganji, F., Abnoos, K., Naghizadeh, H., 2012. In vitro insulin release from thermosensitive chitosan hydrogel.  AAPS PharmSciTech, 13, 460-466.

37- Tafaghodi, M., Saluja, V., Kersten, G.F.A., Kraan, H., Slütter, B., Amorij, J.-P., Jiskoot W., 2012. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: impact of formulation on physicochemical and immunological characteristics. Vaccine, 30, 5341-5348.

38- Moghimipour, E., Tafaghodi, M., Balouchi, A., Handali, S., 2013. Formulation and in vitro Evaluation of Topical Liposomal Gel of Triamcinolone Acetonide. Research Journal of Pharmaceutical, Biological and Chemical Sciences (RJPBCS), 4, 101-107.

39- Hosseinzadeh, H., Tafaghodi, M., Moosavi, M.J., Taghiabadi, E., 2013. Effect of Aqueous and Ethanolic Extracts of Nigella sativa Seeds on Milk Production in Rats. JAMS Journal of Acupuncture and Meridian Studies, 6, 18-23. 

40- Zarifpour, M., Hadizadeh, F., Iman, M., Tafaghodi, M., 2013. Preparation and characterization of trimethylchitosan (TMC) nanospheres encapsulated with tetanus toxoid. Pharmaceutical Sciences, 1(2), 13-18.

41- Dehghan, S., Tavassoti Kheiri, M., Tabatabaiean, M., Darzi, S., Tafaghodi, M., 2013. Dry-powder form of chitosan nanospheres containing infulenza virus and adjuvants for nasal immunization. Archives of Pharmacal Research, 36:981-992.

42- Ganji, F., Khodaverdi, E., Tafaghodi, M., Sadoogh, M., 2013. Effects of Formulation Properties on Sol-Gel Behavior of Chitosan/glycerolphosphate Hydrogel. Iranian Polymer Journal, 22:785-790.

43- Khodaverdi, E., Tafaghodi, M., Beizaei, S., Abnous, Kh., Alibolandi, M., and Hadizadeh, F., 2013. Preparation and Characterization of PLGA-PEG-PLGA nanospheres prepared with a new thermogelling method for Insulin Delivery. Journal of Chemical and Pharmaceutical Research, 5, 311-319.

44- Khameneh Bagheri, B., Momen-nejad, M., Tafaghodi, M., 2014. In vivo evaluation of mucoadhesive properties of nanoliposomal formulations upon coating with trimethylchitosan polymer. Nanomedicine Journal, 1(3), 147-154.

45- Mohammadpour, A.H., Nazemian, F., Hasanzadeh, M., Tafaghodi, M., Salari, P., Charkazi, S., Naghibi, M., Shamsara, J., 2014. Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients. Saudi Journal of Kidney Diseases and Transplantation, 25, 73-78.

46- Razavi Rohani, S.S., Abnous, K., Tafaghodi, M., 2014. Preparation and characterization of spray-dried powders intended for pulmonary delivery of Insulin with regard to the selection of excipients. International Journal of Pharmaceutics, 465, 464-478.

47- Tafaghodi, M., Kersten, G.F.A, Jiskoot, W., 2014. Nano-adjuvanted polio vaccine: Preparation and characterization of chitosan and trimethyl chitosan (TMC) nanoparticles loaded with inactivated polio virus and coated with sodium alginate. Nanomedicine Journal, 1(4), 220-228.

48- Hosseinzadeh, H., Tafaghodi, M., Abedzadeh, S., Taghiabadi, E., 2014. Effect of Aqueous and Ethanolic Extracts of Pimpinella anisum L. Seeds on Milk Production in Rats. Journal of Acupuncture and Meridian Studies, 7(4), 211-216.

49- Ghoochi Atashbeyk, D., Khameneh Bagheri, B., Tafaghodi, M., Fazly Bazzaz, B.S., 2014. Eradication of methicillin-resistant Staphylococcus aureus infection by nanoliposomes loaded with gentamicin and oleic acid. Pharmaceutical Biology, 52 (11), 1423-1428.

50- Mohajer, M., Khameneh, B., Tafaghodi, M., 2014. Preparation and characterization of PLGA nanospheres loaded with inactivated influenza virus, CpG-ODN and Quillaja saponin. 17, 722-726.

51- Khodaverdi, E., Heidari, Z., Sajadi Tabassi, S.A., Tafaghodi, M., Alibolandi, M., Mirzazadeh Tekie, F.S., Khameneh, B., Hadizadeh, F., 2014. Injectable supramolecular hydrogel from insulin-loaded triblock PCL-PEG-PCL copolymer and γ-cyclodextrin with sustained-release property. AAPS PharmSciTech, 16(1), 141-149.

52- Dehghan, S., Tafaghodi, M., Bolourieh, T., Mazaheri, V., Torabi, A., Abnous, KH., Tavassoti Kheiri, M., 2014. Nasal immunaization against influenza by chitosan nanospheres encapsulated with Influenza whole virus and adjuvants in dry-powder form. International Journal of Pharmaceutics, 475, 1-8.

53- Kazemi-Beydokhti, A., Zinali heris, S., Tafaghodi, M., Jaafari, M.R., Hatamipoor, M., 2014. Microwave functionalized single-walled carbon nanotube as nanocarrier for the delivery of anticancer drug cisplatin: in vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology, 24(6), 572-578.

54- Moayedian, T., Mosaffa, F., Khameneh-Bagheri, B., Tafaghodi, M., 2015. Combined effects of PEGylation and particle size on uptake of PLGA particles by macrophage cells. Nanomedicine Journal, 2(4), 299-304.

55- Mehravaran, A., Jaafari, M.R., Jalali, S.A., Khamesipour, A., Tafaghodi, M., Hojatizade, M., Badiee, A., 2015. The role of surface charge of ISCOMATRIX nanoparticles on the type of immune response generated against Leishmaniasis in BALB/c mice. Nanomedicine Journal, 2(4), 249-260.

56- Montaseri, H., Alipour, S., Tafaghodi, M., 2015. Inhalable, large porous PLGA microparticles loaded with pcalitaxel: Preparation, in vitro and in vivo characterization. Journal of Microencapsulation, 32(7), 661-668.

57- Rady Raz, N., Akbarzadeh-T, M.R., Tafaghodi, M., 2015. Bio-inspired Nanonetworks for Targeted Cancer Drug Delivery. IEEE Transaction of Nanobiosience, 14(8), 894-906.

58- Mehravaran, A., Jaafari, M.R., Jalali, S.A., Khamesipour, A., Tafaghodi, M., Hojatizade, M., Badiee, A., 2015. The role of surface charge of ISCOMATRIX nanoparticles on the type of immune response generated against Leishmaniasis in BALB/c mice. Nanomedicine Journal 2 (4), 249-260.

59- Mehravaran, A., Jaafari, M.R., Jalali, S.A., Khamesipour, A., Tafaghodi, M., Hojatizade, M., Abbasi, A., Badiee, A., 2015. Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation. Iranian Journal of Immunology 12 (4), 274.

60- Radvar, M., Moeintaghavi, A., Tafaghodi, M., Ghanbari, H., Fatemi, H., Mokhtari, M.R., Najafi, F., Hoseinipour, Z., Dastmalchi, P., Farazi, F., 2016. Clinical efficacy of herbal mouth wash composed of Salix alba, Malva sylvestris and Althaea officinalis in chronic periodontitis patients. Journal of Herbal Medicine, 6, 24-27.

61- Shiehzadeh, F., Tafaghodi, M., 2016. Dry powder form of polymeric nanoparticles for pulmonary drug delivery. Current Pharmaceutical Design, 22(17), 2549-2560.

62- Amirnasr, M., Fallah-tafti, T., Sankian, M., Rezaei, A., Tafaghodi, M., 2016. Immunization against HTLV-1 with CHT and TMC nanoparticles loaded with recombinant env23 and env13 antigens of envelope protein gp46. Microbial Pathogenesis, 97, 38-44.

63- Alipour, S., Montaseri, H., Nekouian, A.A., Khalili Azad, A., Mohamadpour, A.H., Tafaghodi, M., 2016. Non-invasive endotracheal delivery of paclitaxel loaded alginate microparticles: pharmacokinetic study. Journal of Chemotherapy (In Press).

64- Tafaghodi, M., Jaafari, M-R. Eskandari, M., Khamesipour, A., 2016. Immunization against cutaneous leishmaniasis by Alginate microspheres loaded with Autoclaved Leishmania major (ALM) and Quillaja saponins. Iranian Journal of Pharmaceutical Research (In Press).

65- Hadizadeh, F., Khodaverdi, E., Javan, M., Tafaghodi, M., Sajadi Tabassi, S.A., Chamani, J., Khameneh, B., Mirzazadeh Tekie, F.S., 2016. Sustained Drug Delivery System for Insulin using Supramolecular Hydrogels Composed of Tri-block Copolymers. Submitted to IJPR.

66- Amini, Y., Moradi, B., Tafaghodi, M., Meshkat, Z., Ghazvini, K., Fasihi-Ramandi, M., 2016. TB trifusion antigen adsorbed on calcium phosphate nanoparticles stimulated strong cellular immunity in mice. Submitted to experimental nanoscience.

67- Karimi, S.M., Sankian, M., Khademi, F., Tafaghodi, M., 2016. Chitosan (CHT) and trimethylchitosan (TMC) nanoparticles as adjuvant/delivery system for parenteral and nasal immunization against Mycobacterium tuberculosis (MTb) ESAT-6 antigen. Submitted to Microbiology and Immunology.

68- Pirouzmand, H., Khameneh, B., Tafaghodi, M., 2016. Evaluation of immunoadjuvant potential of dry powder form of cross-linked dextran microspheres (CDM) mixed with chitosan ‎nanospheres encapsulated with tetanus toxoid, after nasal ‎immunization in rabbits. Submitted to Pharmaceutical Biology.

69- Amini, Y., Tafaghodi, M., Amel Jamehdar, S., Meshkat, Z., Moradi, B., Sankian, M., 2016. Heterologous expression, purification and characterization of the HspX, Ppe44 and EsxV proteins of Mycobacterium tuberculosis as a vaccine candidate in prokaryotic system. Submitted to Asian Pacific Journal of Tropical Medicine.

70- Dehghan, S., Kheiri, M.T., … , Tafaghodi, M., 2016. Dry powder vaccine preparation, characterization and immunogenic evaluation of Alginate-based whole inactivated influenza nasal vaccine in rabbits. Submitted to journal of Colloids and Surfaces B.

71- Mosafer, J., Abnous, Kh., Tafaghodi, M., Ramezani, M., 2016. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. Submitted to Applied surface Science.

Presentations

1- Tafaghodi, M. Shokouhi Nejad, H., 1995. Evaluation of different methods of determination of poor soluble substances. Proceeding of the 2^nd congress of Iranian pharmacy students, Mashhad, Iran.

2- Moghimipour E., Dehghan G. and Tafaghodi M., 1998. The study of HPMC concentrations on physical properties of coated tablets. Proceeding of the 6^th Iranian Congress of Pharmaceutical Sciences, Tehran, Iran.

3- Tafaghodi M., Rahimizadeh M., Hassanzadeh M., 2000. Isolation and characterization of alkaloids of Hyoscyamus insanus. Proceeding of the 7^th Iranian Congress of Pharmaceutical Sciences, Mashhad, Iran.

4- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2000. Formulation and characterization of liposomes containing tetanus toxoid. Proceeding of the 7^th Iranian Congress of Pharmaceutical Sciences, Mashhad, Iran.

5- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2002. Preparation and characterization of alginate microspheres encapsulated with tetanus toxoid for nasal delivery. Proceeding of the 8^th Iranian Congress of Pharmaceutical Sciences, Shiraz, Iran.

6- Tafaghodi, M., Diwan, M., Samuel, J., Jaafari, M.R., Sajadi Tabasi, S.A., 2002. Increasing the immune responses by co-delivery of tetanus toxoid and CpG ODN encapsulated in PLGA nanospheres­. Proceeding of the 8^th Iranian Congress of Pharmaceutical Sciences, Shiraz, Iran.

7- Tafaghodi, M., Zakavi, S.R., Sajadi Tabasi, S.A., Jaafari, M.R., Momen Nejad, H., 2002. Gamma-Scintigraphy as a novel method to study the distribution and clearance rate of different mucoadhesive nasal delivery systems. Proceeding of the 6^th Annual Meeting of Nuclear Medicine, Mashhad, Iran.

8- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2003. Nasal immunization using alginate microspheres encapsulated with tetanus toxoid (TT). Proceeding of the 1^st Congress of New Drug Delivery Systems, Tehran, Iran.

9- Sajadi Tabasi, S.A., Tafaghodi, M., Jaafari, M.R.., 2003. Nasal immunization using cross-linked dextran microspheres encapsulated with tetanus toxoid (TT). Proceeding of the 1^st Congress of New Drug Delivery Systems, Tehran, Iran.

10- Tafaghodi, M., Jaafari, M.R.., Sajadi Tabasi, S.A., 2003. Nasal immunization using neutral, cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid (TT). Proceeding of the 1^st Congress of New Drug Delivery Systems, Tehran, Iran.........

11- Tafaghodi, M., Samuel, J., Diwan, M., Sajadi, S.A., Jaafari, M.R., 2003. Utilization of particulate and immunomodulating adjuvants for enhancement of immune response against tumors antigenic markers. Proceeding of the 3rd Congress of National Biotechnology, Mashhad, Iran.

12- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2006. Nasal immunization studies by alginate and cross-linked dextran microspheres and PLGA nanospheres encapsulated with tetanus toxoid (TT). Proceeding of the 10^th Iranian Congress of Pharmaceutical Sciences, Tehran, Iran.

13- Tafaghodi, M., Sajadi Tabasi, S.A., Kharazizadeh, M., 2007. Preparation and characterization of PLGA nonospheres encapsulated with autoclaved Leishmania major (ALM) and saponin adjuvant. Proceeding of the 3^rd Congress of New Drug Delivery Systems, Tehran, Iran.

14- Tafaghodi, M., Hadizadeh, H., Farahmand, F., 2007. Determination of encapsulation efficiency of fluorescent tetanus toxoid in microsphere and Liposome drug delivery systems by spectrofluorimetery method. Proceeding of the 3^rd Congress of New Drug Delivery Systems, Tehran, Iran.

15- Tafaghodi, M., Jaafari, M.R., Amin, M.R., 2007. Nasal Immunization Studies in Rabbits by Anionic and Chitosan Coated Liposomes Encapsulated with Tetanus Toxoid as a Model Antigen. Proceeding of the 1^st Vaccine Congress, Amsterdam, Netherland.

16- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2008. Preparation, characterization and immunization studies with PLGA nonospheres encapsulated with autoclaved Leishmania major (ALM) and saponin adjuvant. Proceeding of the 11^th Iranian Congress of Pharmaceutical Sciences, Kerman, Iran.

17- Tafaghodi, M., 2009. Nanoparticulate drug delivery systems as vaccine adjuvant and delivery system. Proceeding of the Nanodrugs, nano-biotechnology, nano-biosensors and nano-materials in medical sciences. Mashhad, Iran.

18- Tafaghodi, M., Jaafari, M.R., Sajadi, S.A., Khamesipour, A., Amiri, N., 2009. Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. ICRC 2009, Zanjan, Iran.

19- Tafaghodi, M., Mohaghegh, M., 2009. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit. ICRC 2009, Zanjan, Iran. 

20- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2009. Induction of immune responses against leishmaniasis by alginate microspheres encapsulated with autoclaved Leishmania major (ALM) antigen and CpG-ODN.  Proceeding of the 3^rd Modern vaccine adjuvant and delivery systems, Vienna, Austeria.

21- Tafaghodi, M., Jiskoot, W., Saluja, V., 2011. Hepatitis B surface antigen (HBsAg) nanoparticles coated with chitosan and trimethyl chitosan (TMC): impact of formulation on physicochemical and immunological characteristics.

22- Tafaghodi, M., 2016. Polymer based nanoparticles as adjuvant/vaccine delivery system for systemic and mucosal immunizations. 13^th International Congress of Immunology and allergy of Iran. Tabriz, Iran.

Honors & Awards

Honored investigator (student) in medicinal sciences, Ferdowsi Festival, Mashhad, 2001 (Offered by MUMS and FUM).

Honored Pharmacist, Mashhad, 2002 (Offered by Khorasan Association of Pharmacists).

The best presentation in 8^th Iranian Seminar of Pharmaceutical Scientists (Ph.D. student), Shiraz, 2002 (Offered by Iranian Association of Pharmaceutical Scientists).

Honored young researcher, 9^th Iranian Seminar of Pharmaceutical Sciences, Tabriz, 2004 (Offered by Iranian Association of Pharmaceutical Scientists).

The best book translation (Adverse effects of herbal drugs vol. 1 and 2), Research week festival, Mashhad, 2004 (Offered by MUMS)

Three awards from Iranian Nanotechnology Initiative for supervision of two Pharm.D. thesis.

The best book translation (Pharmaceutics, vol. 1), Research week festival, Mashhad, 2006 (Offered by MUMS)

Honored lecturer, MOALEM week festival, Mashhad, 2007 (Offered by MUMS)

The best book translation (Pharmaceutics, vol. 2), Research week festival, Tehran, 2007 (Offered by University of Tehran)

The best book translation (Pharmaceutics, vol. 2), Research week festival, Mashhad, 2007 (Offered by MUMS)

The best presentation in ICRC 2011, Mashhad, 2011 (Offered by Iranian Controlled Release Society).

The best book translation (Nonprescription Drug Therapy), Research week festival, Mashhad, 2011 (Offered by MUMS)

The best book translation (Pharmaceutics, vol. 1), Research week festival, Mashhad, 2015 (Offered by MUMS).

Members                                                  hip Membership

Member of “Nanotechnology Research Center”, Mashhad University of Medical Sciences

Member of “Pharmaceutical Research Center”, Mashhad University of Medical Sciences

Member of “Controlled Release Society of Iran”

Editorial member of Asian Pacific Journal of Tropical Medicine (2009-2011)

Editorial member of Nanomedicine Journal

Reviewer of Drug Development and Industrial Pharmacy journal

Reviewer of Journal of Drug Targeting

Reviewer of Journal of Microencapsulation

Reviewer of Journal of the Taiwan Institute of Chemical Engineers

Reviewer of Iranian Journal of Pharmaceutical Research

Reviewer of Iranian Journal of Basic Medical Sciences

Reviewer of DARU journal

Reviewer of Colloids and Surfaces, B journal

Administrative Responsibilities

Other Skills

Dr Amir Hooshang Mohammadpour

Professor of  Clinical Pharmacy

        [at]mums.ac.ir
[at]yahoo.com

Address: School of Pharmacy, Mashhad University of Medical Sciences

Tel: +98 5138823255

Fax: +98 5138823251

Mohamadpoorah@ mums.ac.ir

This email address is being protected from spambots. You need JavaScript enabled to view it.

Updated at:                           

                                                       und Educational Background 

1999  Pharm D, School of Pharmacy, Ahvaz University of Medical Sciences, Iran

2004  Board Certified Clinical Pharmacy ,School of Pharmacy, Tehran University of Medical Sciences, Iran

2012-2013  Fellowship of Clinical Pharmacokinetic  , School of Pharmacy, University of Rhode Island, USA

                                                                   Research Interests

Clinical trials

 Clinical Pharmacokinetic

 Drug Use Evaluation

                                                                       Publications

1-     Seyedeh Pardis Jahanbakhsh, Ali Akhondpour Manteghi, Seyed Ahmad Emamic,Saman Mahyaria, Beheshteh Gholampourd, Amir Hooshang Mohammadpour,,Amir hossein Sahebkare. “ Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial.” Complementary Therapies in Medicine 27 (2016) 25–29

2-     Saman Mahyari , Behnam Mahyari , Seyed Ahmad Emami , Bizhan Malaekeh-Nikouei , Seyedeh Pardis Jahanbakhsh , Amirhossein Sahebkar ,Amir Hooshang Mohammadpour “ Evaluation of the efficacy of a polyherbal mouthwash containing Zingiber officinale, Rosmarinus officinalis and Calendula officinalis extracts in patients with gingivitis: A randomized double-blind placebo-controlled trial “  Complementary

Therapies in Clinical Practice 22 (2016) 93-98

3-      Mahmoud Hashemzaei, B. Saeed Keykha, C. Fatemeh Shahraki, D. Amir hooshang Mohammadpour and E. Kaveh Tabrizian” EFFECTS OF MAGNESIUM SULFATE ON THE ACQUISITION AND REINSTATEMENT OF MORPHINE-INDUCED CONDITIONED PLACE PREFERENCE IN MICE” J Fundam Appl Sci. 2016, 8(2S), 112-123

4-     Seyed Adel Moallem , Amir Hooshang Mohamadpour , Khalil Abnous , Mojtaba Sankian , Hamid Reza Sadeghnia , Aristidis Tsatsakis , Shabnam Shahsavan. “Erythropoietin in the treatment of carbon monoxide neurotoxicity in rat” Food and Chemical Toxicology 86 (2015) 56-64

5-     Mitra Asgharian Rezaee, Amir Hooshang Mohammadpour, Mohsen Imenshahidi,Mahmoud Mahmoudi, Mojtaba Sankian, Konstantinos Tsarouhas, Andreas Tsakalof,Aristidis Micheal Tsatsakis, Seyed Adel Moallem “Protective effect of erythropoietin on myocardial apoptosis in rats exposed to carbon monoxide ” Life Sciences 148 (2016) 118–124

6-     Tamara Aghebati, Ali Badiee, Amir Hooshang Mohammadpour, Mohammad Afshar, Mahmoud Reza Jaafari, Khalil Abnous, Sobhan Issazadeh, Saeed Hashemzadeh,Mohammad Zareh, Haydeh Hashemizadeh, Saeed Nazemig “Anti-atherosclerosis effect of different doses of CETP vaccine in rabbit model of atherosclerosis” Biomedicine & Pharmacotherapy ; 81 (2016) 468–473

7-    Hashemzaei M, Imen Shahidi M, Moallem SA, Abnous K, Ghorbani M, Mohamadpour AH“Modulation of JAK2, STAT3 and Akt1 proteins by granulocyte colony stimulating factor following carbon monoxide poisoning in male rat” Drug Chem Toxicol. 2016 Jan 25:1-5

8-     Maryam Ghorbani, Amir Hooshang Mohammadpour, Khalil Abnous, Ahmad Reza Movassaghi, Javad Raouf Sarshoori, Shabnam Shahsavand, Mahmoud Hashemzaei andSeyed Adel Moallem “G-CSF administration attenuates brain injury in rats following carbon monoxide poisoning via different mechanisms” Environ Toxicol. 2015 Oct 27. doi: 10.1002/tox.22210. [Epub ahead of print

9-       PARASTOO MIRZABEIGIA, AMIR HOOSHANG MOHAMMADPOURB, MOJTABA SALARIFARC, KHEIROLLAH GHOLAMIA, MOJTABA MOJTAHEDZADEHA AND MOHAMMAD REZA JAVADIA . “The Effect of Curcumin on some of Traditional andNon-traditional Cardiovascular Risk Factors: A Pilot Randomized, Double-blind, Placebo-controlled Trial” . Iranian Journal of Pharmaceutical Research (2015), 14 (2): 479-486

10-  ABOUBAKR RAHMANI, AMIR HOOSHANG MOHAMMADPOUR, ADELEH SAHEBNASAGH, SEYED AHMAD MOHAJERI”  Haloperidol imprinted polymer: preparation, evaluation, and application for drug assay in brain tissue” . Anal Bioanal Chem (2014) 406:7729–7739

11-  SEPIDEH ELYASIA, HOSSEIN KHALILIB*, SIMIN DASHTI-KHAVIDAKIB, HAMID EMADI-KOOCHAKC,AMIRHOOSHANG MOHAMMADPOURA AND ALIREZA ABDOLLAHID   “Elevated Vancomycin Trough Concentration:Increased Efficacy and/or Toxicity?” Iranian Journal of Pharmaceutical Research (2014), 13 (4): 1241-1247

12-  MARYAM VAHABZADEH , AMIR-HOUSHANG MOHAMMADPOUR “Effect of Diabetes Mellitus on the Metabolism of Drugs and Toxins” J Clin Toxicol 2015, 5:2

13-  Ali Gholamzadeh; Sara Amini ; Amir Hooshang Mohammadpour;Maryam Vahabzadeh; Amir Farjam Fazelifar; Afsoon Fazlinezhad; Mashalla Dehghani; Mohsen Moohebati; Mostafa Dastani; Bizhan Malaekeh- Nikouie, ; Homa Falsoleiman“Erythropoietin reduces post-PCI arrhythmias in patients with ST elevation myocardial infarction” Journal of Cardiovascular Pharmacology , 65(6):555-561

14-  Amir Hooshang Mohamadpour,a Leila Abdolrahmani,a Hamed Mirzaei,b Amirhosein Sahebkar,c Mohsen Moohebati,d Maryam Ghorbani,e Gordon A. Ferns,f and Majid Ghayour-Mobarhan “Serum Osteopontin Concentrations in Relation to Coronary Artery Disease”Archive Medical Research, 46 (2015) : 112 – 117

15-   Maryam Amirchaghmaghi • Zahra Delavarian1 • Mehrdad Iranshahi2 • Mohammad Taghi Shakeri • Pegah Mosannen Mozafari • Amir Hushang Mohammadpour • Fatemeh Farazi • Milad Iranshahy.” A Randomized Placebo-controlled Double Blind Clinical Trial of Quercetin for Treatment of Oral Lichen Planus” .  Journal of Dental Research, Dental Clinics, Dental Prospects(2015) : 9 (1)

16-Mahmoudi L , Mohammadpour AH , Niknam R , Ahmadi A , Mojtahedzdeh M . Limited sampling strategy for estimation of amikacin optimal sampling time in critically ill adultsAnaesthesia and Intensive Care , 2014; 42(2):228-233Find all citations by this author (default).Or filter your current search Find all citations by this author (default).Or filter your current search

17-Find all citations by this author (default).

18-Or filter your current search

19-Find all citations by this author (default).

20-Or filter your current search

  17- Mohammad Moshiri, Amir Hooshang Mohammadpour, Maryam Vahabzadeh,

Leila Etemad, Bahram Memar, and Hossein Hosseinzadeh. Evaluating the Effects and Safety of Intravenous Lipid Emulsion on Haloperidol-Induced Neurotoxicity in Rabbit.2014; 108 : 44-47

21-.Milad Iranshahi, Amir Hooshang Mohammadpoor, Mohammad Hassanzadeh Khayyat, Mehrdad Iranshahi. Method validation for the one month stability study of trans resveraterol in human plasma. Jundishapour J Nat Pharm Prod, 2013; 8(2); 65-9

22-.Maryam Ghorbani , Amir Hooshang Mohamadpour , Soghra Mehri ,Khalil Abnous , Mohammad Hassanzadeh-Khayyat.  Proteomics screening of molecular targets of granulocyte colony stimulating factor in the mouse brain and PC12 cell line. Life Sciences. 2014 In Press

23-. Leila Etemad , Afshar Mohammad , Amir Hooshang Mohammadpour , Nasser Vahdati Mashhadi , Seyed Adel Moallem . Teratogenic Effects of Pregabalin in Mice. Iran J Basic Med Sci. 2013; 16: 1065-1070

24-.Mohammadpour AH, Akhlaghi F. Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective. Clin Pharmacokinet. 2013 52(8):615-626

25-Moshiri M¹, Vahabzadeh M, Mohammadpour AH, Hosseinzadeh H.  Evaluation of intravenous lipid emulsion on haloperidol-induced hypotension in rabbits. Toxicol Ind Health. 2014 Jan 20. [Epub ahead of print]

26-Mohammadpour AH, Nazemian F¹, Khaiat MH, Tafaghodi M, Salari P, Charkazi S, Naghibi M, Shamsara J.  Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients. Saudi J Kidney Dis Transpl. 2014 Jan;25(1):73-8.

27-.Maryam Vahabzadeh, Mohammad Moshiri,  Amir Hooshang Mohammadpour, and Hossein Hosseinzadeh,  Promising Effects of Intravenous Lipid Emulsion as an Antidote in Acute Tramadol Poisoning. Regional Anesthesia and Pain Medicine, 2013; 38(5): 425-30

28-Amir Hooshang Mohammadpour, Homa Falsoleiman, Jamal Shamsara, Ghazaleh Allah Abadi, Ramin Rasooli ,Mohammad Ramezani .Pentoxifylline Decreases Serum Level of Adhesion Molecules in Atherosclerosis Patients. Iranian Biomedical Journal. Iran Biomed J. Jan 2014; 18(1): 23–27

29-.Amir Hooshang Mohammadpour, Fatemeh Nazemian, Jamal Shamsara, Maryam Bafandegan, Maryam Ghorbani1 and Seyed Adel Moallem . Effects of omega-3 administration on concentration of serum inflammatory makers in renal transplant recipient .African Journal of  Pharmacy and Pharmacology.  2013; 7 (29): 2021-2024

30-. Amir Hooshang Mohammadpour, Mohammad Ramezani, Nasim Tavakoli Anaraki, Bizhan Malaekeh-Nikouei, Sara Amel Farzad, and Hossein Hosseinzadeh.Development and Validation of HPLC Method for Determination of Crocetin, a constituent of Saffron, in Human Serum Samples. Iran J Basic Med Sci. 2013 January; 16(1): 47–55

31-.Maryam M Ghorbani, Seyyed Adel S Moallem, Khalil K Abnous, Seyyed Abbas SA Tabatabaee Yazdi, Ahmad Reza AR Movassaghi, Mohammad M Azizzadeh, Amir Hooshang AH Mohamadpour* Drug Chem Toxicol 36(1):102-8 (2013), The effect of granulocyte colony-stimulating factor administration on carbon monoxide neurotoxicity in rats. Drug Chem Toxicol.2013; 36(1):102-8

32-.Mahmoudi L, Mohammadpour AH, Ahmadi A, Niknam R, Mojtahedzadeh M. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients Eur Rev Med Pharmacol Sci. 2013 Feb;17(3):285-91.

33-AH Mohamadpour, Z Ayati, MR Parizadeh, O Rajbai, H Hosseinzadeh . Safety Evaluation of Crocin (a constituent of saffron) Tablets in Healthy Volunteers
Iranian journal of basic medical sciences. 2013; 16 (1), 39-46

34-.G Kamalinia, S Brand, P Ghaeli, N Abedi, H Bajoghli, V Sharifi, A Zahiroddin , AH Mohammadpour . Serum Levels of Sodium Valproate in Patients Suffering from Bipolar Disorders: Comparing Acute and Maintenance Phases of Mania
Pharmacopsychiatry. 2013;46(3):83-7

35-AH Mohammadpour, SA Moallem, M Bafandegan, J Shamsara, F Nazemian. Effects of omega-3 administration on homocysteine serum concentration in renal transplant recipient ,Journal of Pharmaceutical Care .2013;1 (1), 25-28

36-25.M Hassanzadeh Bashtian, SA Emami, N Mousavifar, HA Esmaily, M Mahmoudi, AH Mohammadpour Evaluation of Fenugreek Effects (Trigonella foenum-graceum L.) Seeds Extract on Insulin Resistance in Women with Polycystic Ovarian Syndrome . Iranian Journal of Pharmaceutical Research. 2013;12(2):475-481

37-Vahid Jomezadeh, Amir Hooshang Mohammadpour,Omid Rajabi, Alireza Tavassoli, Ghodratolah MaddahEvaluation of Curcumin Effects on Post-Operative Peritoneal Adhesion in Rats. Iran J Basic Med Sci. 2012 Nov-Dec; 15(6): 1162–1167.

38-Shabnam Shahsavand, Amir Hooshang Mohammadpour, Ramin Rezaee, Effat Behravan, Ramin Sakhtianchi,and Seyed Adel Moallem^. Effect of Erythropoietin on Serum Brain-derived Biomarkers after Carbon Monoxide Poisoning in Rats. Iran J Basic Med Sci. 2012 Mar-Apr; 15(2): 752–758.

39-Shamsara J,Mohammadpour AH, Behravan J,Falsoleiman H,Ramezani M.”Pentoxifylline decreases soluble CD40 ligand concentration and CD40 gene expression in coronary artery disease patients”Immunopharmacol Immunotoxicol. 2012;34(3)523-9

40-Elyasi S,Khalili H,Dashti-Khavidaki S,Mohammadpour A.”Vancomycin-induced nephrotoxicity:mechanism,incidence,risk factors and special populations.A literature review”.Eur J Clin Pharmacol. 2012 Sep;68(9):1243-55

41-Amir Hooshang Mohammadpour,Jamal Shamsara,Saeed Nazemi,Samira Ghadirzadeh,Shabnam Shahsavand and Mohammad Ramezani.”Evaluation of RANKL/OPG serum concentration ratio as a new biomarker for coronary artery calcification:a pilot study.” Thrombosis. 2012; Epub 2012 Mar 28

42-Mohammad Reza Khakzad,Majid Mirsadraee,Amirhooshang Mohammadpour,Kamran Ghafarzadegan,Raziye Hadi,Mahdiye Saghari,Mojtaba Meshkat.”Effect of verapamil on bronchial goblet cells of asthma: an experimental study on sensitized animals” Pulmonary Pharmacology & Therapeutics.(2012);25:163-168.

43-Amir Hooshang Mohammadpour,Saeed Nazemi,Maryam Foroughi,Maryam Ghorbani,Jamal Shamsara and Javad Behravan.” Evaluation of the association between AT 1 R1166C polymorphism and the incidence of CAD and CAC score in Iranian population ”.Arch.Biol.Sci,Belgrade,2012;64(2),401-407

44-Jamal Shamsara, Javad Behravan, Homa Falsoleiman, Amir Houshang Mohammadpour, Mohammad Ramezani. The effects of pentoxifylline administration on NFΚB P50 transcription factor expression. ARYA A therosclorosis. 2012;7 (4):133-137

45-.Aghebati T, Foroughipour M, Azarpazhooh MR, Mokhber N, Hasanzadeh Khayat M, Vahdati N, Mohammadpour AH*. Relationship between Patient Demographic Characteristics, Valproic Acid Dosage and Clearance in Adult Iranian Patients. Iran J Basic Med Sci. 2012 Mar;15(2):702-8

46-.Mitra Asgharian Rezaeea, Seyed Adel Moallem, Mohsen Imenshahidi, Mahdi Farzadniac and Amir Hooshang Mohammadpour*Effects of Erythropoietin on Electrocardiogram Changes in Carbon Monoxide Poisoning: an Experimental Study in Rats.  Iranian Journal of Pharmaceutical Research .2012; 11 (4): 1191-1199

47-S Lotfi Noghabi, A Vahidian Kamyad, M Foroughipour, AH Mohammadpour Estimating the Optimal Dosage of Sodium Valproate in Idiopathic Generalized Epilepsy with Adaptive Neuro-Fuzzy Inference System. Basic and Clinical Neuroscience .2012;3 (3): 24-31

48-Jamal Shamsara,Javad Behravan,Homa Falsoleiman,Amir Hooshang Mohammadpour,Joerg Renderis,Mohammad Ramezani.Pentoxifylline administration changes protein expression profile of coronary artery disease patients. 2011 Nov 1;487(1):107-11

49-Amir Hooshang Mohammadpour, Fatemeh Nazemian, Reza K, Reza Kouhrokhi,Mohammad Ramezani , Jamal Shamsara “Effect Of Omega-3 Fatty Acids On Plasma Level Of 8-Isoprostane In Kidney Transplant Patients” Journal of Renal Nutrition , 2011; 21(2): 196-199

50-Amir Hooshang Mohammadpour,Fatemeh Nazemian,Seyed Adel Moallem,Seyed Ali Alamdaran,Elham Asad-Abadi,Jamal Shamsara. Correlation between Heat-Shock Protein 27 serum concentration and common carotid intima-media thickness in hemodialysis patients.Iranian Journal of Kidney Diseases.2011; 5:260-6 2011.

51-Mohamadpour AH, Moallem SA, Hashemzaei M, Abnous K, Tabatabaee Yazdi SA, Imenshahidi M.” Effects of granulocyte colony-stimulating factor on electrocardiogram changes after carbon monoxide poisoning in rats” Drug Chem Toxicol. 2012 ; 35(4),353-360.

52-Amir Hooshang Mohammadpour,Mohsen Foroughipour, Mahmoud Reza Azarpazhooh, Mohammad Hasanzadeh Khayat,Saeed Rezaee,Tamara Aghebati,Jamal Shamsara. Comparison of valporic acid clearance between epileptic patients and patients with acute mania.Iranian journal of basic medical sciences. 2011;14(6): 546-550

53-.Niloufar Mohammadpour, Sepideh Elyasi,Naser vahdati,Amir Hooshang Mohammadpour*,Jamal Shamsara.A review on therapeutic drug monitoring of Immunosuppressant drugs. Iranian journal of basic medical sciences, 2011; 14(6), 485-498

54-Seyed adel Moallem, Fatemeh Nazemian , Sepideh Eliasi ,Seyed Ali Alamdaran, Jamal Shamsara, Amir Hooshang Mohammadpour^* “Correlation between CathepsinD serum concentration and carotid intima media thickness in hemodialysis patients” Int Urol Nephrol 2011 Sep;43(3):841-8

55-.Mehdi Bakhshaee, Farahzad Jabbari, Saeed Hoseini, Reza Farid, Mohammad Hadi Sadeghian, Mohsen Rajati, Amir Houshang Mohamadpoor, Rahman Movahhed, and Mohammad Ali Zamani. Effect of Silymarin in the Treatment of Allergic Rhinitis. Otolaryngology–Head and Neck Surgery. 2011;145(6) :904–909

56-N.Moosavifar,AH Mohammadpour,M Jallali,G karimi and H saberi.Evaluation of effect of silymarin on granulose cell apoptosis and follicular development in patients undergoing in vitro fertilization.Eastern meditererranean Health Journal.2010; 16(6):642-45.

57- Afshar M, Moallem SA, Houshang Mohammadpour A, Shiravi A, Majid Jalalian S, Jafar Golalipour M.” Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice” Cutan Ocul Toxicol. 2010 Mar;29(1):10-15

58-Amir Hooshang Mohammadpour, Fatemeh Nazemian, Gholamreza Karimi, Mahdi Moatamedi, Somayeh Charkazi, Jamal Shamsara . “ Effect of Silymarin Administration on TNF-α serum concentration in peritoneal dialysis” Phytotherapy Research, 2010; 24: 1654-1657

59-Foroughipour M, Mohammadpour AH*, Azarpajooh MR, Mokhber N, Hasanzadeh Khaiat M, Rezaee S, Aghebati T, Vahdati N, Shamsara J “Therapeutic Drug Monitoring of valproic acid in patients with monotherapy at steady state”: Iranian Journal of Basic Medical science. 2009;12(3):146-149

60-Bazzaz BS, Naderinasab M, Mohamadpoor AH, Farshadzadeh Z, Ahmadi S, Yousefi F. The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran. Acta Microbiol Immunol Hung. 2009 Mar;56(1):89-99.

61-.J Shamsara, M Ramezani, AH Mohammadpoor*Why homocysteine-lowering therapy does not have beneficial effects on patients with cardiovascular disease?
Bioscience Hypotheses .2009 ;2 (1):13-15

62-Amir Hooshang Mohammadpur, Fatemeh Nazemian, Bahareh Abtahi, Massih Naghibi “Influence of renal graft function on mycophenolic acid pharmacokinetics during the period after kidney transplant”. Experimental and Clinical Transplantation. 2008; 4:276-281

63-Mohammadpour AH, Nazemian F, Abtahi B, Naghibi M, Rezaee S, Rajzbi O “ Estimation of abbreviated Mycophenolic acid area under the concentration time curve during post transplant period by limited sampling strategy” Transplantation Proceeding . 2008,;40:3668-3672 

64-Mohammad Pour AH, Nazemian F, Hassanzadeh Khayat M, Bahrami A.A., Kazemi M. “Effect of Gancyclovir on Pharmacokinetics of Mycophenolate Mofetil in Kidney Transplant Patients” Iranian Journal of Basic Medical Sciences. 2008; 10 (4): 233-238

65-Nazemian F, Mohammadpur AH^*, Abtahi B, Naghibi M “Pharmacokinetics of mycophenolic acid during the early period after renal transplant: Exprimental and clinical transplantation. 2007; 5 (2): 658-63

66-M Abbasi Nazari, AH Mohammadpour, J Behjati ardakani, , MR Rouini, KH Gholami The effect  of atenolol on thyroid hormons  in subclinical  hyperthyroidism , Iranian Journal of Pharmaceutical Sciences. 2005;1(4): 243-248

67-Mohammadpoor AH, sadraee S, Ghaeli P, foroughipoor M, Noroozian M, Rezaee S. Comparison of carbamazepin clearance between epileptic patients and paitents with acute Mania, DARU, 2004; 12 (4): 141-144

                                                                      Presentations

                                                                    Honors & Awards

2011  Outstanding Scientist Award, Mashhad University of Medical Sciences

2016 Outstanding Educational Award, Mashhad University of Medical Sciences

Membership

Rational Use of Drugs Council, Mashhad University of Medical Sciences, Mashhad, Iran

Ethic committee  Research Council, Mashhad University of Medical Sciences, Mashhad, Iran

                                                           Administrative Responsibilities

2006-2012 Chair of Department of Pharmacodinamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

2009-2011 , vice chancellor for research, School of Pharmacy, Mashhad University of Medical

Sciences, Mashhad, Iran

2013 -2016 Chair of Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Other Skills

Dr. Gholamreza Karimi

Professor of Pharmacology and Toxicology

        [at]mums.ac.ir
[at]yahoo.com

Address:

Tel:

Fax

karimig [at]mums.ac.ir

……….[at]yahoo.com

Updated at:                           

                                                       und Educational Background 

Cardiovascular pharmacology and toxicology

                                                                   Research Interests

Cardiovascular pharmacology and toxicology

                                                                       Publications

1. Kobra Shirani, Faezeh Vahdati Hassani, Kamal Razavi Azar-Khiavi, Zohreh Samie Moghaddam and Gholamreza Karimi*. Determination of methanol in Iranian herbal distillates. J Complement Integr Med. 2016; aop
2.  Nafiseh Sadat Alamolhodaei  ,Kobra Shirani  ,Gholamreza Karimi ,∗.Arsenic cardiotoxicity :An overview,Environmental Toxicology and Pharmacology 40(2015)1005–1014
3. Maryam Rahnama, Mahmoud Mahmoudi, Shahrzad Zamani Taghizadeh Rabe, Mahdi Balali-Mood, Gholamreza Karimi, Nafiseh Tabasi, and Bamdad Riahi-Zanjani. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model. J Immunotoxicol, Volume 12, Issue 3, 1 July 2015, Pages 231-238. (IF:1.22)
4.  Mahmoudi M, Zamani Taghizadeh Rabe S, Balali-Mood M, Karimi G, Memar B, Rahnama M, Tabasi N, Khazaee M, Riahi-Zanjani B. Immunotoxicity induced in mice by subacute exposure to berberine. J Immunotoxicol. Volume 13, Issue 2, 3 March 2016, Pages 255-262.  (IF:1.22)
5. Hassani FV, Rezaee R, Sazegara H, Hashemzaei M, Shirani K, Karimi G. Effects of silymarin on neuropathic pain and formalin-induced nociception in mice. Iran J Basic Med Sci. 2015 Jul;18(7):715-20.
6.  Bamdad Riahi-Zanjani, Mahdi Balali-Mood, Elaheh Mohammadi, Hassan Badie-Bostan, Bahram Memar, Gholamreza Karimi*. Safranal as a safe compound to mice immune system. AJP, Vol. 5, No. 5, Sep-Oct 2015. ISC 
7.  Mahmoud Mahmoudi; Shahrzad Zamani Taghizadeh Rabe; Maryam Rahnama ; Mahdi Balali Mood; Gholamreza Karimi  ; Bamdad Riahi-Zanjani ,*. Use of Carnosol as a Highly Immunosuppressive Agent.  Jundishapur J Nat Pharm Prod. 2015 August; 10(3): e20824.  Pubmed
8. Gholami, M.  ; Moallem, S.A.;  Afshar, M. ; Etemad, L. * ; Karimi, G. Maternal Exposure to  Silymarin  Leads to  Phatological Changes in mouse  Foetuses. Pharmacology online, Volume 2, 2015, Pages 38-43. Scopus
9. Faezeh Vahdati Hassani   , Ramin Rezaee         , Hasan Sazegara , Mahmoud    Hashemzaei , Kobra  Shirani   , Gholamreza Karimi   * . Effects     of  silymarin   on           neuropathic  pain     and     formalin‐induced        nociception      in         mice. Iran J Basic Med Sci, Vol. 18, No. 7, Jul 2015 .ISI
10. Amir  Hooshang  Mohammadpour, Alireza  Tavassoli, Mohammad  Reza  Khakzad,  Elahe  Zibaee, Mohammad ,AfsharMahmoud Hashemzaei , Gholamreza Karimi*. Effect of gold nanoparticles on  postoperative peritoneal adhesions in rats. Nanomed J, Vol. 2, No. 3, Summer 2015.ISC 
11. Kobra Shirani a ,Faezeh Vahdati Hassani a ,Kamal Razavi-Azarkhiavi a ,Somayeh Heidari a ,Bamdad Riahi Zanjani b ,Gholamreza Karimi c,∗ Phytotrapy of cyclophosphamide-induced immunosuppression.  Enviromental toxicology  and pharmacology . 2015 May;39(3):1262-1275. IF:2.084
12. Mahmoud Mahmoudi, Shahrzad Zamani Taghizadeh Rabe, Mahdi Balali-Mood, Gholamreza Karimi , Nafiseh Tabasi and Bamdad Riahi-Zanjani* . Ursolic acid induced apoptotic cell death following activation of caspases in isolated human melanoma cells. Cell Biol Int,39(2015) 230–236. IF:1.933 
13.  Parisa Mirhoseini Moosavi, Ali Reza Astaraei ,Alireza Karimi, Mohammad Moshiri, Leila Etemad, Majid Zeinalid, Gholamreza Karimi. Efficacy of orally administered montmorillonite for acute iron poisoning detoxification in rat. Applied Clay Science 103 (2015) 62–66. IF:2.467
14. Ramin Rezaee, Khadijeh Jamialahmadi , Bamdad Riahi Zanjani, Mahmoud Mahmoudi .Crocin Effects on Human Myeloma Cells Regarding Intracellular Redox State, DNA Fragmentation, and Apoptosis or Necrosis Profile. Jundishapur J Nat Pharm Prod. 2014 November; 9(4). Pubmed
15. Bamdad Riahi-Zanjani, Mahdi Balali-Mood, Seyed-Reza Mousavi, Gholamreza Karimi, Mahmood Sadeghia, Elham Shirmast, Mahmoud Mahmoudi. Serum cytokine profiles of Khorasan veterans 23 years after sulfur mustard exposure. Cytokine. 2014 Dec;70(2):161-4.
16. Kobra Shirani, Javad Behravan, Fatemeh Mosaffa, Mehrdad Iranshahi, Babak  Mehmankhah, Kamal Razavi-Azarkhiavi, Karimi, G*,.Evaluating the effects of galbanic acid on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. AJP, Vol. 4, No. 5, Sep-Oct 2014

1. R.   Jabini . R.   Jaafari . F.   Vahdati Hasani .F.   Ghazizadeh .A.   Khamesipour , G.   Karimi

Effects of Combined Therapy with Silymarin and Glucantime on Leishmaniasis Induced by Leishmania  major in BALB/c Mice. Drug Res. 2014 Mar 12

1. Adeleh Sahebnasagh , Karimi, G*, Seyed Ahmad Mohajeri.  Preparation and Evaluation of Histamine Imprinted Polymer as a Selective Sorbent in Molecularly Imprinted Solid-Phase Extraction Coupled with High Performance Liquid Chromatography Analysis in Canned Fish. Food Anal. Methods (2014) 7:1–8. (IF:1.969)
2. Maryam Rahnama, Mahmoud Mahmoudi, Shahrzad Zamani Taghizadeh Rabe, Mahdi Balali-Mood, Gholamreza Karimi, Nafiseh Tabasi and Bamdad Riahi-Zanjani. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model. J Immunotoxicol, Volume 12, Issue 3, 1 July 2015, Pages 231-238
3.  Khadijeh Jamialahmadia,, Omid Arastehc, Maryam Matbou Riahi, Soghra Mehrid, Bamdad Riahi-Zanjanie, Karimi, G*,. Protective effects of glucosamine hydrochlorideagainst free radical-induced erythrocytes damage. Damage. Environmental Toxicology and Pharmacology 3 8 ( 2 0 1 4 ) 212–219(IF: 1.862)
4.  Z Tayarani-Najaran , A Amiri , Karimi, G, SA Emami , J Asili, S H Mousavi. Comparative Studies of Cytotoxic and Apoptotic Properties of Different Extracts and the Essential Oil of Lavandula angustifolia on Malignant and Normal Cells. Nutrition and Cancer, 2014 Apr;66(3):424-34(IF: 2.47)
5.  Shiezadeh F, Mousavi SH, Sadegh Amiri M, ranshahi M, Tayarani-Najaran Z and Karimi, G* .Cytotoxic and Apoptotic Potential of Rheum turkestanicum Janisch Root Extract on Human Cancer and Normal Cells. Iranian journal of pharmaceutical science . 2013: 12( 4), Autumn 2013, 811-819
6. Razavi-Azarkhiavi K, Behravan J, Mosaffa F, Sehatbakhsh S, Shirani K, Karimi G. Protective effects of aqueous and ethanol extracts of rosemary on H2O2-induced oxidative DNA damage in human lymphocytes by comet assay. J Complement Integr Med. 2014 Feb 4;11(1):27-33. doi: 10.1515/jcim-2013-0063.
7. Hamid Reza Sadeghnia, Faezeh Vahdati Hassani, Hamid Sadeghian, Maryam Miandehi, Farzin Hadizadeh and Karimi, G*. Evaluation of in vitro toxicity of peptide 3 (N-acetyl-Leu-Gly-Leu-COOH)-substituted-β- 4 cyclodextrin derivative, a novel drug carrier, in 5 PC-12 cells. Sadeghnia et al. DARU Journal of Pharmaceutical Sciences 2013, 21:75. (IF:1.11)
8. Ali Reza Hosseininia , Maryam Vahabzadeh , Marziyeh Rashedinia , Bamdad Riahi-Zanjani,

Karimi, G*. A survey of aflatoxins in sesame seeds imported into Khorasan Province, Iran. Mycotoxin Res. 2013, DOI 10.1007/s12550-013-0186-7.

1. Ramin Rezaee, Mahmoud Mahmoudi, Khalil Abnous, Shahrzad Zamani, Taghizadeh Rabe,

Nafiseh Tabasi, Mahmoud Hashemzaei and Karimi, G *.Cytotoxic effects of crocin on MOLT-4 human leukemia cells. J Complement Integr Med. 2013; 10(1): 1–8

1. Taghiabadi E, M Imenshahidi, Kh Abnous, F Mosafa, M Sankian,B Memar,6 and Karimi G*. Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice.  Evidence-Based Complementary and Alternative Medicine. Volume 2012, 14  pages. (IF:2.18)
2. HosseinBoskabady M , karimi G , Samarghandian S , Farkhondeh T. Tracheal responsiveness to methacholine and ovalbumin; and lung inflammation in guinea pigs exposed to inhaled lead after sensitization. Ecotoxicology and Environmental Safety ,2012, 86 : 233–238(IF:2.294)
3. Maleki M, Karimi G, Tafaghodi M, Raftari S, Nahidi Y. Comparison of Intralesional Two Percent Zinc Sulfate and Glucantime Injection in Treatment of Acute Cutaneous Leishmaniasis. Indian Journal of Dermatology, 2012, 57;118-122. (IF:0.388)
4. Akbari B   , Gharanfoli F , Hassanzadeh Khayyat M, Khashyarmanesh Z  ,  Rezaee R , Karimi G*. Determination of heavy metals in different honey brands from Iranian market, Food Additives and Contaminants, 2012 , 5: 1-7. (IF:1.765)
5. Rezaee R, Hassanzadeh-Khayyat M, Khashyarmanesh Z, Moallemzadeh Z, F Mehri F, Karimi G*. Determination of parathion, aldicarb and thiobencarb in tap water and bottled mineral water in Mashhad , Iran. Drug and Chemical Toxicology, 2012, 35:1-7.(IF:1.082)
6.  Karimi G*,aghasizadeh M, razavi M, taghiabadi E. Protective effects of aqueous and ethanolic extracts of Nigella sativa L.and portulaca oleracea L. on free radical induced hemolysis of RBCs.DARU,2011,19:295-300. .(IF:0.773)
   1. Mohajeri S, Karimi G, Aghamohammadian J, Rajabnia khansari M. Clozapine recognition via molecularly imprinted polymers;bulk polymerization versus precipitation method. Journal of Applied Polymer Science, 2011, 121:3590-3595. (IF:1.289)
   2. Karimi G*, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. Silymarin a promising pharmacological agent for treatment of disease. IJBMS, 2011, 14:308-317. (IF:0)
   3. Mohammadi H, Karimi G, Rezayat SM, Dehpour AR, Shafiee H, Nikfar S, Baeeri M, Sabzevari O, Abdollahi M. Benefit of nanocarrier of magnetic magnesium in rat malathion-induced toxicity and cardiac failure using non-invasive monitoring of electrocardiogram and blood pressure. Toxicol Ind Health.2011, 27:417-429(IF:1.423)
   4.  Hosseinzadeha L, Behravanb J, Mosaffab F, Bahramic G, Bahramidand A, Karimi G*. Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species. Food and Chemical Toxicology. 2011, 49: 1102-1109(IF:2.999)
   5.  Riahi, B., Rafatpanah, H., Mahmoudi, M., Memar, B., Brook, A., Tabasi, N., Karimi, G.* Evaluation of suppressive effect of paraquat on innate immunity in Balbc mice. J Immunotoxicology, 2011, 8:39-45(IF:1.22)
   6.  Hosseinzadeh L, Behravan J, Mosaffa F, Karimi G*. Effect of curcumin on doxorubicin induced cytotoxicity in H9C2 cardiomyocyte cells. IJBMS, 2011, 14:49-56(IF:0)
   7. Mohajeri A, Karimi G, Rajabnia m.Clozapine imprinted polymers: synthesis, ccharacterization and application for drug assay In human serum. Analytica Chimica Acta, 2010, 683: 143-148. (IF:4.555)
   8. Karimi G*, Hosseinzadeh h, Rassoulzadeh M, Razavi M, Taghiabadi E. Antinociceptive effect of Elaeagnus angustifolia fruits on sciatic nerve ligated mice. IJBMS, 2010, 13: 97-101. (IF:0)
   9. Nazemian F, Karimi G. Moatamedi M, Charkazi S, Shamsara J, Mohamadpoor A. Effects of Silymarin administration on TNF-α Serum concentration in peritoneal dialysis patients. Phytotherapy Res, 2010, 24:1654-1657(IF:2.086)
   10.  Karimi G*, Khoei A, Omidi A, Kalantari M, Babaei J, Taghiabadi E, Razavi M. Protective Effects of Aqueous and Ethanolic Extracts of Portulaca oleraceae against cisplatin induced nephrotoxicity. IJBMS, 2010, 13: 31-35. (IF:0)
   11.  Karimi G*, Moallem A, Hasanzadeh M, Bozorgi M, Nilli-Ahmadabadi A, Nazari F. Exposure assessment for mercury from consumption of marine fish in Iran. Toxicological & Environmental Chemistry . 2010, 92: 1213-1218. (IF:2.809)
   12.  Imenshahidi, M., Karimi, G., Kazemzadeh, E.Effects of atorvastatin on nitrate tolerance in diabetic rats. Iranian Journal of Pharmaceutical Research. 2010, 9: 55-59. (IF:0. 637)
   13. Riahi, B., Rafatpanah, H., Mahmoudi, M., Memar, B., Brook, A., Tabasi, N., Karimi, G*.- Immunotoxicity of paraquat after subacute exposure to mice.Food and Chemical Toxicology. 2010, 48: 1627-1631.(IF:2.999)
   14.  Soltani, F., Mosaffa, F., Iranshahi, M., Karimi, G., Malekaneh, M., Haghighi, F., Behravan, J. Auraptene from Ferula szowitsiana protects human peripheral lymphocytes against oxidative stress. Phytotherapy Research. 2010, 24: 85-89. (IF:2.086)
   15. Hadizadeh F., Rahimi B., Taghiabadi E.  , Razavi M., Karimi G*. Evaluation of anticonvulsant effect of two novels 4-[1-(4-fluorobenzyl)-5-imidazolyl] dihydropyridine derivatives in mice. Research in Pharmaceutical Sciences, May 2013; 8(2): 91-95
   16. -Imenshahidi M 1, Rezaee R 2, MostofI A , Karimi G  *. Evaluation of nitric oxide or opioid receptors involvement in antinociceptive properties of silymarin1. AJP, 2012 , 2:39-45

1. Iranshahi M, Khoshangosht M, Mohammadkhani Z, Karimi G*. Protective effect of aqueous and ethanolic extract of saffron stigma and petal on liver toxicity in duced by carbon tetrachloride in mice. Pharmacologyonline , 2011,1: 203-212
   1. Behravan J, Mosaffa F, Soudmand N, Taghiabadi E, Razavi M,Karimi G*. Protective effects of aqueous and ethanolic extracts of Portulaca oleracea L. aerial parts H2O2-induced DNA damage in lymphocytes by comet assay. J Acupunct Meridian Stud( jams) .2011,4:193-197
   2. Karimi G*, Iranshahi M, Hosseinzadeh F, Riahi B, Sahebkar A. Screening of acetylcholinesterase inhibitory activity of terpenoid and coumarin derivatives from the gens ferula. Pharmacologyonline, 2010, 1: 566-574
   3. Moosavifar N, Mohammad poor A, Jalali M, Karimi G, Saberi H. Evaluation of silymarin effect on granulose cell apoptosis and follicular development inpatients in patients undergoing IVF. EMHJ, 2010, 16 : 460-463
   4. Karimi, G*., Tabrizian, K., Rezaee, R.Evaluation of the Analgesic Effect of Dextromethorphan and its Interaction With Nitric Oxide on Sciatic Nerve Ligated Rats. Journal of Acupuncture and Meridian Studies. 2010, 3: 38-42
   5. Roohbakhsh, A., Karimi, G*.- In vitro evaluation of xanthine oxidase inhibitory activity of aqueous extracts of six medicinal plants. Journal of Medicinal Plants. 2009, 8: 84-91.
   6. -Karimi, G.*, Imenshahidi, M., Jafarizaveh, E., Asgharian Rezaee, M.Vasodilator effect of olive leaf aqueous extract and involvment of cyclooxygenase in the rat aorta. Pharmacologyonline. 2009, 2: 365-371
   7. Karimi, G*.., Hassanzadeh, M., Shahidi, N., Samie, Z.Quantitative determination of methanol in plant water produced in Mashhad by spectrophotometry method. Journal of Medicinal Plants. 2008, 7:56-59
   8. Karimi, G*., Saradeghi Keisari, M. Evaluation of antidepressant effect of ethanolic and aqueous extracts of Silybum marianum L. seed in mice. Journal of Medicinal Plants. 2007, 6: 38-43
   9. Behravan, J., Mosaffa, F., Karimi, G.Iranshahi, M. In vitro protective effects of Satureja hortensis L. essential oil and ethanolic extract on lymphocytes DNA. Journal of Medicinal Plants. 2007, 6: 64-70
   10. -Karimi, G*., Hassanzadeh, M., Mehri, S. Protective effects of silymarin against free radical-induced erythrocyte lysis. Journal of Complementary and Integrative Medicine. 2006, 3: 1553-3840
   11.  Karimi, G*., Taiebi, N., Hosseinzadeh, Shirzad, F.Evaluation of subacute toxicity of aqueous extract of Crocus sativus L. stigma and petal in rats.Journal of Medicinal Plants. 2004, 3: 29-35
   12. Hosseinzadeh, H., Karimi, G., Niapoor, M.- Antidepressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice.Journal of Medicinal Plants. 2004, 3: 48-58
   13. Hosseinzadeh, H., Karimi, G., Rakhshanizadeh, M.Anticonvulsant effects of aqueous and ethanolic extracts of Hypericum perforatum L. in mice.Journal of Medicinal Plants. 2004, 3: 23-30
   14. Hosseinzadeh, H., Karimi, G., Ameri, M.Effects of Anethum graveolens L. seed extracts on experimental gastric irritation models in mice. BMC Pharmacology. 2002, 19; 2-21.
   15. Iranshahi, M., Noroozi, S., Behravan, J., Karimi, G., Schneider, B.Persicasulphide C, a new sulphur-containing derivative from Ferula persica. Natural Product Research .2009, 23: 1584-1588(IF:1.009)
   16. Soltani, F., Mosaffa, F., Iranshahi, M., Karimi, G., Malekaneh, M., Haghighi, F., Behravan, J. Evaluation of antigenotoxicity effects of umbelliprenin on human peripheral lymphocytes exposed to oxidative stress.Cell Biology and Toxicology. 2009,25: 291-296. (IF:2.511)
   17. Noroozi, S., Mosaffa, F., Soltani, F., Iranshahi, M., Karimi, G., Malekaneh, M., Haghighi, F., Behravan, J. Antigenotoxic effects of the disulfide compound persicasulfide A (PSA) on rat lymphocytes exposed to oxidative stress. Planta Medica. 2009,75::32-36. (IF:2.04)
   18. Karimi, G*, Hassanzadeh, M., Yazdanpanah, H., Nazari, F., Iranshahi, M., Nili, A.Contamination of patulin in clear apple juice in Mashhad, Iran. Journal of Food Safety. 2008, 28: 413-421. (IF:1.9)
   19. Karimi, G*, Fatehi, Z., Gholamnejad, Z.The role of nitric oxide and protein kinase C in lipopolysaccharide- mediated vascular hyporeactivity. Journal of Pharmacy and Pharmaceutical Sciences. 2006, 9: 119-123. (IF:1. 914)
   20. Mosaffa, F., Behravan, J., Karimi, G., Iranshahi, M.Antigenotoxic effects of Satureja hortensis L. on rat lymphocytes exposed to oxidative stress. Archives of Pharmacal Research. 2006, 29:159-164. (IF:1.592)
   21. Karimi, G*., Ramezani, M., Abdi, A. Protective effects of lycopene and tomato extract against doxorubicin-induced cardiotoxicity. Phytotherapy Research. 2005, 19: 912-914. (IF:2.08)
   22. Karimi, G*., Ramezani, M., Tahoonian, Z. Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evidence-based Complementary and Alternative Medicine. 2005, 2: 383-386. (IF:4.7)
   23. Hosseinzadeh, H., Karimi, G .Rakhshanizadeh, M.- Anticonvulsant effect of Hypericum perforatum: Role of nitric oxide. Journal of Ethnopharmacology. 2005, 98: 207-208(IF:3.7)
   24. Karimi, G*., Hosseinzadeh, H., Ettehad, N.Evaluation of the gastric antiulcerogenic effects of Portulaca oleracea L. extracts in mice. Phytotherapy Research. 2004, 18: 484-487.(IF: 2.08)
   25. Karimi, G*., Khoshbaten, A., Abdollahi, M., Sharifzadeh, M., Namiranian, K., Dehpour, A.R. Effects of subacute lead acetate administration on nitric oxide and cyclooxygenase pathways in rat isolated aortic ring. Pharmacological Research. 2002, 46: 31-37(IF:2.6)
   26. Abdollahi, M., Jalali, N., Sharifzadeh, M., Karimi, G. Attempted suicide by insulin injection treated with hypertonic glucose solution. Medical Journal of the Islamic Republic of Iran .1998, 12: 85-87

                                                                      Presentations

• Karimi G, Behravan J, Mosaffa F, Hosseinzadeh L, Bahrami G. Curcumin potentiates doxorubicin induced apoptosis in h cardiac muscle cells through generation of reactive oxygen spec.12 th Iranian congress of biochemistry & 4 th International congress of biochemistry and molecular biology.Mashhad ,Iran, 6-9 September, 2011. PP(357)
• -Hosseinzadeh L, Karimi G .Vation of nuclear factor kappab by doxorubicin leads to ibition of extrinsic pathway of apoptosis in H9c2 cells. 12 th Iranian congress of biochemistry & 4 th International congress of biochemistry and molecular biology.Mashhad ,Iran, 6-9 September, 2011. PP(44)
• Hosseinzadeh L, Karimi G. Effect of crocin and thymoquinone on doxorubicin- induced cytotoxicity in H9c2 CELLS. Proceeding of 10th Annual Congress of  Asia Pacific Association of medical toxicology, Penang, Malaysia, 11-14 November 2011. PP(101)
• Mehri F, Rezaee R, Hassanzadeh-Khayyat M, Karimi G . Assay of thiobencarb, aldicarb and parathion in tap water and bottled mineral water in Mashhad, Iran. 11th International congress of Toxicology, Mashhad, Iran, 13-15 September, 2011.(p195)
• Myelin damage after CO poisoning was recovered by erythropoietin. 12th Iranian Congress of Toxicology, Sari, Iran, 15-17 May 2013.

• The role of microRNA in cardiovascular disease. 12th Iranian Congress of Toxicology, Sari, Iran, 15-17 May 2013.
• Protective effects of glucosamine hydrochloride against AAPH induced hemolysis. 12th Iranian Congress of Toxicology, Sari, Iran, 15-17 May 2013.
• Should crocin be regarded as an effective medicine against Human Myeloma cells? 12th Iranian Congress of Toxicology, Sari, Iran, 15-17 May 2013.
• Preparation and evaluation of histamine imprinted polymer as a selective sorbent in molecularly imprinted solid-phase extraction coupled with high performance liquid chromatography analysis in canned fish. 12th Iranian Congress of Toxicology, Sari, Iran, 15-17 May 2013.
• Protective effect of vitamin E against acrolein-inducedcardiotoxicity in mice. 12th Iranian Congress of Toxicology, Sari, Iran, 15-17 May 2013.
• Immunotoxicity of paraquat after subacute exposure to mice. 12th Iranian Congress of Toxicology, Sari, Iran, 15-17 May 2013.

                                                                    Honors & Awards

Members                                                  hip Membership

                                                           Administrative Responsibilities

Head of pharmacology and toxicology department,  2000-2002

Manager of pharmacology Lab, 2000 up to now

Manager of Mashhad drug and poison information center, 2000 up to 2012

Deputy food and drug organization in Mashhad University 2005 up to 2012

Head of pharmacology and toxicology department,  2014-2016

Other Skills